Annual Report • Aug 6, 2020
Annual Report
Open in ViewerOpens in native device viewer
NN Group N.V. 30 June 2020 Condensed consolidated interim financial information
| Condensed consolidated interim financial information | Page | |
|---|---|---|
| Interim report | 2 | |
| Overview | 2 | |
| Analysis of results | 4 | |
| Capital management | 6 | |
| Segments | 9 | |
| Balance sheet | 20 | |
| Conformity statement | 21 | |
| Interim accounts | 22 | |
| Condensed consolidated balance sheet | 22 | |
| Condensed consolidated profit and loss account | 23 | |
| Condensed consolidated statement of comprehensive income | 24 | |
| Condensed consolidated statement of cash flows | 25 | |
| Condensed consolidated statement of changes in equity | 27 | |
| Notes to the Condensed consolidated interim accounts | 29 | |
| 1 | Accounting policies | 29 |
| 2 | COVID-19 pandemic | 29 |
| 3 | Financial assets at fair value through profit or loss | 30 |
| 4 | Available-for-sale investments | 31 |
| 5 | Loans | 32 |
| 6 | Associates and joint ventures | 33 |
| 7 | Intangible assets | 34 |
| 8 | Other assets | 34 |
| 9 | Equity | 34 |
| 10 | Insurance and investment contracts, reinsurance contracts | 36 |
| 11 | Other liabilities | 37 |
| 12 | Investment income | 37 |
| 13 | Underwriting expenditure | 38 |
| 14 | Earnings per ordinary share | 39 |
| 15 | Segments | 39 |
| 16 | Taxation | 43 |
| 17 | Fair value of financial assets and liabilities | 44 |
| 18 | Companies and businesses acquired and divested | 47 |
| 19 | Other events | 50 |
| 20 | Subsequent events | 50 |
| 21 | Capital management | 51 |
| Authorisation of the Condensed consolidated interim accounts | 52 | |
| Other information | 53 | |
| Review report | 53 |
1 2 3
Founded in 1845, NN Group N.V. ('NN Group') is a financial services company, active in 18 countries, with a strong presence in a number of European countries and Japan. Over the past 175 years, NN Group has been dedicated to meeting and exceeding customers' expectations. The purpose of NN Group is to help people care for what matters most to them. Through its products and services, NN Group wants to create value for its customers and other stakeholders. With all its employees, NN Group provides retirement services, pensions, insurance, investments and banking to approximately 18 million customers.
NN Group is committed to do business in a way that is consistent with its values: care, clear, commit. NN Group is committed to resilient and growing long-term capital generation and cash flows for shareholders. NN Group has a clear ambition to achieve sustainable value creation for all stakeholders through disciplined capital deployment whilst remaining resilient during volatile financial markets.
More information about NN Group's business model, values and performance is available on www.nn-group.com and in the NN Group Annual Report.
Since early 2020, the spread of the coronavirus (the COVID-19 pandemic) is causing significant disruption to society and the world-wide economy, impacting NN Group, its employees, its customers and its suppliers. Financial markets have been severely impacted by significant decreases in interest rates, equity prices and spread widening and the world-wide economy has been significantly impacted as well. Governments and central banks worldwide are responding to this crisis with aid packages and further supporting measures. At the date of this report, the depth and length of this crisis is unknown. NN Group is constantly monitoring the developments and the (potential) impact on NN Group. The most significant risks that NN Group is facing in this context are related to the financial markets (including interest rates, equity prices and spreads), insurance risk (including mortality and policyholder behaviour) and operational risk (continuity of business processes). The notes to the 2019 annual accounts include extensive disclosure on the exposure to such risks and the risk management thereof; these disclosures remain valid.
The COVID-19 pandemic, and the related impact on the financial markets, impacted the results of NN Group in the first half of 2020 mainly in the following areas:
In the first half of 2020, there were no significant impairments of other assets (including debt securities, loans and intangible assets). Furthermore, there was no significant impact from the COVID-19 pandemic on the technical provisions for insurance contracts.
At the date of this report, it is too early to determine the structural impact of the COVID-19 pandemic on results, capitalisation and longer term assumptions, if any. Also the amount and profitability of new sales may be impacted but, at the date of this report, it is too early to assess any (potential) structural impact.
NN Group has established a business continuity plan to help ensure the continuity of its businesses, the well-being of its staff and its capability to support its customers, whilst maintaining financial and operations resilience.
In April 2020 NN Group completed the acquisition of VIVAT Schadeverzekeringen N.V. ('VIVAT Non-life'). NN Group announced in June 2019 that it had acquired VIVAT Non-life for a consideration of EUR 416 million. VIVAT Non-life was acquired from Athora Holding Ltd. ('Athora'), following the acquisition of the VIVAT Group (VIVAT) by Athora. In addition, NN Group acquired the intercompany Tier 2 loans granted by VIVAT to VIVAT Non-life for a consideration of EUR 150 million plus accrued interest. The approvals for the acquisition were received in the first quarter of 2020. The transaction closed on 1 April 2020. As a result, VIVAT Non-life is included in the consolidation in the reporting for the first half of 2020 as of 1 April 2020.
In May 2020, NN Group announced that it had completed three transactions to transfer the full longevity risk associated with in total approximately EUR 13.5 billion of pension liabilities in the Netherlands. This will reduce NN Group's exposure to longevity risk, and consequently reduce the required capital and further strengthen NN Group's capital position. These transactions cover the risks associated with the policies of over 200,000 pensioners and dependants. The longevity reinsurance agreements have no impact on the services and guarantees that NN Group provides to its policyholders.
The transactions have been entered into with reinsurance companies Canada Life, Munich Re and Swiss Re. The risk transfer is effective as of 1 January 2020, and the reinsurance agreements will continue until the portfolio has run off.
On 6 April 2020 NN Group announced that it would act in accordance with the recommendations of EIOPA and the Dutch Central Bank (DNB) published on 2 April 2020, which urged insurers to temporarily suspend their dividend distributions and share buyback programmes as a consequence of the COVID-19 pandemic.
Although NN Group is well capitalised and has a strong liquidity position, it decided to postpone the payment of dividends on its ordinary shares in line with the EIOPA and DNB recommendations. The proposal to pay a 2019 final dividend that was included in the 2019 Annual Accounts was not included in the agenda of the annual general meeting of 28 May 2020. In addition, the EUR 250 million share buyback programme, which commenced on 2 March 2020, was suspended. Up to and including 3 April 2020, shares for a total amount of EUR 183 million had been repurchased under this programme.
The proposed 2019 final dividend was already deducted from Solvency II Own Funds as at 31 December 2019 and reflected in the 2019 solvency ratio as disclosed in the 2019 Annual Report. Following the decision not to propose a 2019 final dividend, there was no deduction in the final 2019 Solvency ratio that was filed with the regulator. As a result, the final Solvency ratio at 31 December 2019 was 224% (compared with 218% as disclosed in the 2019 Annual Report). There was no impact on shareholders' equity under IFRS.
The suspension of the share buyback programme did not impact the Solvency ratio at 31 December 2019. The shares that were bought under the programme until 3 April 2020 are deducted from shareholders' equity and own funds in the first half of 2020.
Reference is made to Note 9 'Equity' for the 2020 interim dividend and to Note 20 'Subsequent events' for the re-start of the share buyback programme.
Robert Ruijter stepped down from the Supervisory Board as at 12 April 2020.
Dick Harryvan stepped down from the Supervisory Board as at 28 May 2020. Following his resignation, Hélène Vletter-van Dort was appointed as new vice-chair.
NN Group N.V.
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Netherlands Life | 494 | 524 |
| Netherlands Non-life | 111 | 84 |
| Insurance Europe | 133 | 140 |
| Japan Life | 138 | 118 |
| Asset Management | 74 | 76 |
| Banking | 80 | 60 |
| Other | -104 | -88 |
| Operating result | 926 | 914 |
| Non-operating items: | 57 | 593 |
| – of which gains/losses and impairments | 168 | 94 |
| – of which revaluations | 167 | 573 |
| – of which market and other impacts | -278 | -75 |
| Special items | -123 | -108 |
| Acquisition intangibles and goodwill | -13 | 17 |
| Result on divestments | 8 | |
| Result before tax | 846 | 1,424 |
| Taxation | 250 | 296 |
| Minority interests | 9 | 10 |
| Net result | 587 | 1,118 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| New sales life insurance (APE) | 620 | 1,188 |
| Value of new business | 122 | 236 |
| Total administrative expenses | 1,043 | 1,030 |
| Operating capital generation1 | 543 | 697 |
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Solvency II ratio2 | 221% | 224% |
1 NN Group analyses the change in the excess of Solvency II Own Funds over the Solvency Capital Requirement ('SCR') in the following components: Operating Capital Generation, Market variance, Capital flows and Other. Operating Capital Generation is the movement in the Solvency II surplus (Own Funds before eligibility over SCR at 100%) in the period due to operating items, including the impact of new business, expected investment returns in excess of the unwind of liabilities, release of the risk margin, operating variances, non-life underwriting result, contribution of non-Solvency II entities and holding expenses and debt costs and the change in the SCR. It excludes economic variances, economic assumption changes and non-operating expenses.
2 The solvency ratio is not final until filed with the regulators. The Solvency II ratio for NN Group is based on the partial internal model. The year-end 2019 NN Group Solvency II ratio was restated to reverse the deduction of the proposed 2019 final dividend following the decision to suspend dividend payments in light of the recommendations of EIOPA and the Dutch Central Bank (DNB).
Note: For definitions and explanations of the Alternative Performance Measures reference is made to the Note 15 'Segments' in section 'Alternative Performance measures (Non-GAAP measures)'.
NN Group's operating result increased to EUR 926 million from EUR 914 million in the first half of 2019, which benefited from EUR 67 million of private equity and special dividends, while the first half of 2020 includes EUR 16 million of private equity dividends and non-recurring benefits.
The impact of COVID-19 on the operating result for the first half of 2020 was around EUR 30 million, mainly in the segments Japan Life, Asset Management, Other, Insurance Europe and Banking. The restrictions in place to halt the spread of the virus have also led to lower new sales in Europe and Japan in the current period. The lower new business volumes will impact results going forward.
The administrative expenses of the business units in the scope of the cost reduction target decreased by EUR 21 million in the first half of 2020, bringing the administrative expense base down to EUR 1,589 million on a last 12-months basis. Total cost reductions achieved to date amount to EUR 381 million compared with the full-year 2016 administrative expense base of EUR 1,970 million.
The operating result of Netherlands Life was EUR 494 million compared with EUR 524 million in the first half of 2019, reflecting a lower investment margin as the first half of 2019 benefited from EUR 67 million of private equity and special dividends, while the first half of 2020 mainly reflects a higher technical margin and lower administrative expenses.
The operating result of Netherlands Non-life increased to EUR 111 million from EUR 84 million in the first half of 2019, reflecting the inclusion of the results of VIVAT Non-life of EUR 20 million as from 1 April 2020, as well as higher underwriting results in Property & Casualty, partly offset by lower underwriting results in Disability & Accident.
The operating result of Insurance Europe decreased to EUR 133 million from EUR 140 million in the first half of 2019, which included a nonrecurring benefit of EUR 6 million. Excluding this item, the operating result was broadly stable in the first half of 2020 reflecting a negative impact from COVID-19 of EUR 4 million, offset by higher life protection fees and higher pension fees in Romania.
The operating result of Japan Life was EUR 138 million, up 12.1% from the first half of 2019, excluding currency effects, reflecting improved persistency partly offset by a negative impact of COVID-19 of EUR 9 million.
The operating result of Asset Management was broadly stable at EUR 74 million in the first half of 2020. The impact of COVID-19 was EUR -8 million due to the volatile markets which put pressure on fee income.
The operating result of Banking increased to EUR 80 million from EUR 60 million in the first half of 2019, mainly driven by a higher interest result and higher investment and other income, which includes a EUR 7 million non-recurring benefit. The COVID-19 impact in the first half of 2020 was EUR -4 million reflecting higher operating expenses for acceptance processes and arrears management as well as higher additions to loan loss provisions.
The operating result of the segment Other was EUR -104 million versus EUR -88 million in the first half of 2019, mainly reflecting a lower operating result of the reinsurance business, partly offset by a higher holding result. The impact of COVID-19 was EUR -5 million for the first half of the year, related to the reinsurance business.
The result before tax decreased to EUR 846 million from EUR 1,424 million in the first half of 2019, primarily due to lower non-operating items mainly reflecting the volatile markets as a result of COVID-19.
Gains/losses and impairments were EUR 168 million compared with EUR 94 million in the first half of 2019, mainly reflecting higher capital gains on the sale of debt securities and public equities, partly offset by higher impairments on equities.
Revaluations amounted to EUR 167 million versus EUR 573 million in the first half of 2019. The first half of 2020 includes EUR 223 million positive revaluations of derivatives used for hedging purposes mainly reflecting accounting asymmetries, partly offset by negative revaluations on real estate.
Market and other impacts amounted to EUR -278 million compared with EUR -75 million in the first half of 2019. The first half of 2020 reflects movements in the provision for guarantees on unit-linked, separate account pension contracts and inflation-linked liabilities (all net of hedging) at Netherlands Life.
Special items amounted to EUR -123 million compared with EUR -108 million in the first half of 2019, mainly reflecting restructuring expenses incurred in respect of the cost reduction target as well as expenses related to the VIVAT Non-life acquisition.
Acquisition intangibles and goodwill amounted to EUR -13 million versus EUR 17 million in the first half of 2019, which included the negative goodwill recognised on the acquisition of the Czech and Slovak businesses.
The net result in the first half of 2020 decreased to EUR 587 million from EUR 1,118 million in the first half of 2019. The effective tax rate in the first half of 2020 was 29.5%, reflecting a relatively high tax charge on the investment income, amongst others due to impairments and negative revaluations on tax-exempt investments.
Total new sales (APE) were EUR 620 million, down 48.6% from the first half of 2019 on a constant currency basis. New sales at Netherlands Life were EUR 178 million compared with EUR 328 million in the first half of 2019. As from 2020, new sales related to defined contribution (DC) accumulation contracts are no longer reported as insurance new sales but are reported as part of the DC assets under management. At Japan Life, new sales were down 77.1% from the first half of 2019, excluding currency effects, reflecting strong sales in the first quarter of 2019 ahead of the implementation of the revised tax regulations of COLI products, as well as COVID-19 restrictions. New sales at Insurance Europe were down 6.1% on a constant currency basis, mainly due to lower life and pension sales across the region as a result of COVID-19 restrictions.
Value of new business was EUR 122 million, down from EUR 236 million in the first half of 2019 due to strong sales in Japan in the first quarter of 2019 ahead of the implementation of the revised tax regulations of COLI products, as well as lower sales in Japan and Insurance Europe in the first half of 2020.
Solvency II
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Basic Own Funds | 19,510 | 19,491 |
| Non-available Own Funds | 1,123 | 1,252 |
| Eligible Own Funds to cover Solvency Capital Requirements (a) | 18,388 | 18,240 |
| – of which Tier 1 unrestricted | 12,235 | 11,836 |
| – of which Tier 1 restricted | 1,938 | 1,922 |
| – of which Tier 2 | 2,470 | 2,474 |
| – of which Tier 3 | 500 | 703 |
| – of which non-Solvency II regulated entities | 1,244 | 1,305 |
| Solvency Capital Requirements (b) | 8,338 | 8,154 |
| – of which Solvency Capital Requirements calculated on the basis of consolidated data | 7,852 | 7,612 |
| – of which the capital requirements for investment firms, pension funds and credit institutions | 188 | 249 |
| – of which the capital requirements for undertakings included under the D&A method | 298 | 294 |
| NN Group Solvency II ratio (a/b)1 | 221% | 224% |
1 2 3 Interim report
1 The solvency ratio is not final until filed with the regulators. The Solvency II ratio for NN Group is based on the partial internal model. The year-end 2019 NN Group Solvency II ratio was restated to reverse the deduction of the proposed 2019 final dividend following the decision to suspend dividend payments in light of the recommendations of EIOPA and the Dutch Central Bank (DNB).
The NN Group Solvency II ratio decreased to 221% from 224% at the end of 2019, mainly reflecting the proposed 2020 interim dividend and the EUR 183 million share buybacks executed in the first half of 2020, the acquisition of VIVAT Non-life, the impact of the UFR reduction from 3.90% to 3.75% and unfavourable market impacts. These items were partly offset by the positive impact of the longevity transactions executed by NN Life in May 2020 and operating capital generation. Market impacts mainly reflect movements in credit spreads and negative equity revaluations.
On 11 July 2020, the Dutch Central Bank (DNB) published new regulations in which the required approach to calculating the Solvency II ratio was revised. As from 31 December 2020, NN Group will be required to include NN Bank in the calculation of its Solvency II ratio. The pro forma NN Group Solvency II ratio including NN Bank is 211% as at 30 June 2020.
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| June 2020 | June 2019 | |
| Investment return | 569 | 509 |
| Life - UFR drag | −421 | −243 |
| Life - Risk margin release | 215 | 206 |
| Life - Experience variance | 37 | −4 |
| Life - New business | 53 | 108 |
| Non-life underwriting | 43 | 22 |
| Non-Solvency II entities (Asset Management, Japan Life, Bank, Other1 ) |
152 | 220 |
| Holding expenses and debt costs | −141 | −133 |
| Change in SCR | 35 | 12 |
| Operating capital generation | 543 | 697 |
1 Other comprises Europe pension funds as well as broker and services companies; dividends from Banking.
| 1 January to 30 | 1 January to 30 |
|---|---|
| June 2020 | June 2019 |
| 376 | 441 |
| 61 | 49 |
| 119 | 130 |
| 70 | 70 |
| 50 | 62 |
| 0 | 56 |
| −133 | -111 |
| 543 | 697 |
NN Group's operating capital generation decreased to EUR 543 million from EUR 697 million in the first half of 2019. The decrease reflects the negative impact of lower interest rates, the suspension of dividend payments from NN Bank and a lower new business contribution in Insurance Europe as a result of COVID-19 restrictions. This was partly offset by a higher investment return mainly in Netherlands Life reflecting the shift to higher-yielding assets and the inclusion of the results of VIVAT Non-life as from 1 April 2020 in the Netherlands Non-life business.
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Cash capital position — opening balance | 1,989 | 2,005 |
| Cash divestment proceeds | 4 | |
| Remittances from subsidiaries1 | 718 | 1,459 |
| Capital injections into subsidiaries2 | -52 | -76 |
| Other3 | -209 | -200 |
| Free cash flow to the holding4 | 458 | 1,187 |
| Acquisitions | -572 | -117 |
| Capital flow from/ (to) shareholders | -260 | -1,085 |
| Increase/ (decrease) in debt and loans | -300 | |
| Cash capital position — closing balance | 1,315 | 1,989 |
1 Includes interest on subordinated loans provided to subsidiaries by the holding company.
2 Includes the change of subordinated loans provided to subsidiaries by the holding company.
3 Includes interest on subordinated loans and debt, holding company expenses and other cash flows.
4 Free cash flow to the holding company is defined as the change in cash capital position of the holding company over the period, excluding acquisitions, capital transactions with shareholders and debtholders.
The cash capital position at the holding company decreased to EUR 1,315 million from EUR 1,989 million at the end of 2019. The decrease mainly reflects the EUR 572 million consideration paid for the acquisition of VIVAT Non-life, the redemption of EUR 300 million senior debt and the repurchase of EUR 260 million of own shares, partly offset by EUR 718 million of remittances from subsidiaries. The line 'Other' includes holding company expenses, interest on loans and debt, and other holding company cash flows for a negative amount of EUR 209 million.
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Shareholders' equity | 35,117 | 30,768 |
| Adjustment for revaluation reserves1 | -17,519 | -13,397 |
| Minority interests | 256 | 260 |
| Capital base for financial leverage (a) | 17,854 | 17,632 |
| – Undated subordinated notes2 | 1,764 | 1,764 |
| – Subordinated debt | 2,396 | 2,409 |
| Total subordinated debt | 4,159 | 4,172 |
| Debt securities issued | 1,693 | 1,992 |
| Financial leverage (b) | 5,852 | 6,164 |
| Financial leverage ratio (b/(a+b)) | 24.7% | 25.9% |
| Fixed-cost coverage ratio2,3 | 11.1x | 12.0x |
1 Includes revaluations on debt securities, on the cash flow hedge reserve and on the reserves crediting to life policyholders.
2 The undated subordinated notes classified as equity are considered financial leverage in the calculation of the financial leverage ratio. The related interest is included on an accrual basis in the calculation of the fixed-cost coverage ratio.
3 Measures the ability of Earnings Before Interest and Tax (EBIT) to cover funding costs on financial leverage; calculated on a last 12-months basis.
The financial leverage ratio of NN Group improved to 24.7% compared with 25.9% at the end of 2019, driven by the redemption of EUR 300 million senior debt.
The fixed-cost coverage ratio decreased to 11.1x compared with 12.0x at the end of 2019 (on a last 12-months basis).
| Credit ratings | ||
|---|---|---|
| Financial | NN Group N.V. | |
| Strength | Counterparty | |
| Rating | Credit Rating | |
| Standard & Poor's | A | BBB+ |
| Stable | Stable | |
| Fitch | A+ | A |
| Stable | Stable |
On 27 May 2020, Standard & Poor's published a report affirming NN Group's 'A' financial strength rating and 'BBB+' credit rating with a stable outlook.
On 29 April 2020, Fitch Ratings published a report affirming NN Group's 'A+' financial strength rating and 'A' credit rating with a stable outlook.
Netherlands Life
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Investment margin | 433 | 482 |
| Fees and premium-based revenues | 201 | 209 |
| Technical margin | 98 | 81 |
| Operating income | 731 | 772 |
| Administrative expenses | 221 | 230 |
| DAC amortisation and trail commissions | 17 | 17 |
| Total expenses | 237 | 248 |
| Operating result | 494 | 524 |
| Non-operating items: | 149 | 564 |
| – of which gains/losses and impairments | 211 | 15 |
| – of which revaluations | 212 | 614 |
| – of which market and other impacts | -274 | -64 |
| Special items | -32 | -20 |
| Result on divestments | 5 | |
| Result before tax | 612 | 1,073 |
| Taxation | 192 | 224 |
| Minority interests | 7 | 5 |
| Net result | 413 | 844 |
Key figures
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| New sales life insurance (APE) | 178 | 328 |
| Value of new business | 9 | 1 |
| Total administrative expenses | 221 | 230 |
| Operating capital generation | 376 | 441 |
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| NN Life Solvency II ratio1 | 226% | 213% |
1 The solvency ratio is not final until filed with the regulators. The Solvency II ratio for NN Life is based on the partial internal model.
Operating capital generation of Netherlands Life was EUR 376 million in the first half of 2020, compared with EUR 441 million in the first half of 2019. The decrease was mainly due to the net negative impact of the UFR drag and risk margin release as a result of lower interest rates as well as the negative impact of the longevity reinsurance transactions, partly offset by a higher investment return reflecting the shift to higher-yielding assets.
The operating result was EUR 494 million compared with EUR 524 million in the first half of 2019, reflecting a lower investment margin as the first half of 2019 benefited from EUR 67 million of private equity and special dividends, while the current half-year mainly reflects a higher technical margin and lower administrative expenses.
The investment margin decreased to EUR 433 million compared with EUR 482 million in the first half of 2019 which benefited from private equity and special dividends for a total amount of EUR 67 million whereas the current half-year included a EUR 9 million private equity dividend. Lower dividends as a result of COVID-19 were largely compensated by higher income from other asset classes driven by the shift to higher-yielding assets.
Fees and premium-based revenues decreased to EUR 201 million from EUR 209 million in the first half of 2019, due to the run-off of the individual life closed book as well as lower margins in the pension business.
The technical margin increased to EUR 98 million from EUR 81 million in the first half of 2019. The current half-year reflects higher longevity results as well as higher morbidity results, partly offset by the reinsurance premiums related to the longevity transactions completed in May 2020.
Administrative expenses decreased to EUR 221 million from EUR 230 million in the first half of 2019 mainly driven by lower staff expenses.
DAC amortisation and trail commissions were in line with the first half of 2019 at EUR 17 million.
The result before tax decreased to EUR 612 million from EUR 1,073 million in the first half of 2019 due to lower non-operating items, mainly reflecting the volatile markets as a result of COVID-19 and the lower operating result.
Gains/losses and impairments increased to EUR 211 million in the first half of 2020 from EUR 15 million in the same period last year. The current half-year mainly reflects capital gains on the sale of government bonds and public equities, partly offset by impairments on equities.
Revaluations decreased to EUR 212 million compared with EUR 614 million in the first half of 2019. The current half-year reflects positive revaluations on derivatives used for hedging purposes reflecting accounting asymmetries, partly offset by negative revaluations on real estate.
Market and other impacts were EUR -274 million versus EUR -64 million in the first half of 2019, mainly reflecting movements in the provisions for guarantees on unit-linked, separate account pension contracts and inflation-linked liabilities (all net of hedging).
New sales (APE) were EUR 178 million compared with EUR 328 million in the first half of 2019. As from 2020, new sales related to defined contribution (DC) accumulation contracts are no longer reported as insurance new sales but are reported as part of the DC assets under management. On a comparable basis, based on the new definition, new sales (APE) were down by 8% compared to the first half of 2019.
The value of new business was EUR 9 million in the first half of 2020 compared with EUR 1 million in the same period last year.
On 31 March 2020, the Court of Appeal in The Hague decided in the collective action initiated by Woekerpolis.nl against NN to refer preliminary questions to the Dutch Supreme Court to obtain clarity on various principal points of law related to unit-linked products. On 29 July 2020, the District Court in Rotterdam rejected all claims of Consumentenbond and ruled that NN has provided sufficient information on the effect of costs and premiums. These rulings do not change earlier statements and conclusions disclosed by NN Group in relation to unit-linked products. NN continues to reach out to customers to encourage them to carefully assess their unit-linked products in order to find an appropriate solution on an individual basis, where needed.
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Earned premiums | 1,638 | 1,477 |
| Investment income | 50 | 55 |
| Other income | -2 | -1 |
| Operating income | 1,686 | 1,531 |
| Claims incurred, net of reinsurance | 1,137 | 1,045 |
| Acquisition costs | 291 | 262 |
| Administrative expenses | 157 | 154 |
| Acquisition costs and administrative expenses | 448 | 416 |
| Expenditure | 1,585 | 1,461 |
| Operating result insurance businesses | 101 | 70 |
| Operating result health business and broker business | 11 | 14 |
| Total operating result | 111 | 84 |
| Non-operating items: | -36 | 12 |
| – of which gains/losses and impairments | -24 | 8 |
| – of which revaluations | -16 | 4 |
| – of which market and other impacts | 4 | |
| Special items | -35 | -26 |
| Result before tax | 40 | 70 |
| Taxation | 10 | 15 |
| Minority interests | 5 | |
| Net result | 30 | 50 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| Gross premium income | 2,093 | 1,956 |
| Total administrative expenses1 | 202 | 191 |
| Combined ratio:2 | 94.9% | 96.8% |
| – of which Claims ratio2 | 67.5% | 68.7% |
| – of which Expense ratio2 | 27.4% | 28.2% |
| Operating capital generation | 61 | 49 |
1 Including non-insurance businesses (health business and broker business).
2 Excluding non-insurance businesses (health business and broker business).
Operating capital generation of Netherlands Non-life was EUR 61 million compared with EUR 49 million in the first half of 2019, reflecting the acquisition of VIVAT Non-life as well as higher underwriting results in Property & Casualty (P&C), partly offset by lower results in Disability & Accident (D&A).
The operating result increased to EUR 111 million from EUR 84 million in the first half of 2019, reflecting the inclusion of the results of VIVAT Nonlife of EUR 20 million as from 1 April 2020, as well as higher underwriting results in P&C, partly offset by lower underwriting results in D&A. The combined ratio improved to 94.9% from 96.8% in the first half of 2019.
The operating result in D&A decreased to EUR -20 million from EUR 39 million in the first half of 2019. The first half of 2020 reflects lower underwriting results including higher claims experience due to COVID-19, the reduction of the discount rate of the IFRS technical provisions to reflect the current low interest rate environment, as well as unfavourable claims development in the Individual Disability portfolio which was partly covered by reinsurance with NN Re. The contribution of the aforementioned acquisition to the operating result of D&A was broadly neutral. The D&A combined ratio was 103.1% versus 93.7% in the first half of 2019.
The operating result in P&C increased to EUR 120 million from EUR 31 million in the first half of 2019, reflecting higher underwriting results, mainly in the Fire and Motor portfolios, including favourable run-off results and a positive impact from COVID-19, as well as the aforementioned acquisition. The P&C combined ratio improved to 90.8% from 98.5% in the first half of 2019.
The increase in administrative expenses to EUR 157 million from EUR 154 million in the first half of 2019 reflects the impact of the VIVAT Non-life acquisition, partly offset by expense reductions.
The operating result of the non-insurance businesses decreased to EUR 11 million from EUR 14 million in the first half of 2019.
The result before tax of Netherlands Non-life decreased to EUR 40 million from EUR 70 million in the first half of 2019, mainly reflecting lower non-operating items and higher special items, partly offset by the contribution from the VIVAT Non-life acquisition and the higher operating result. Lower non-operating items include impairments on public equity as well as lower revaluations on private equity and real estate reflecting the volatile markets as a result of COVID-19.
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Investment margin | 48 | 49 |
| Fees and premium-based revenues | 367 | 360 |
| Technical margin | 125 | 120 |
| Operating income non-modelled business | 1 | 1 |
| Operating income Life Insurance | 541 | 530 |
| Administrative expenses | 214 | 206 |
| DAC amortisation and trail commissions | 196 | 189 |
| Expenses Life Insurance | 410 | 396 |
| Operating result Life Insurance | 131 | 134 |
| Operating result Non-life | 2 | 5 |
| Operating result | 133 | 140 |
| Non-operating items: | -22 | 36 |
| – of which gains/losses and impairments | -1 | 65 |
| – of which revaluations | -14 | -28 |
| – of which market and other impacts | -7 | -1 |
| Special items | -13 | -17 |
| Acquisition intangibles and goodwill | 33 | |
| Result before tax | 98 | 191 |
| Taxation | 24 | 36 |
| Net result | 74 | 156 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| New sales life insurance (APE) | 319 | 348 |
| Value of new business | 84 | 108 |
| Total administrative expenses (Life and Non-life) | 220 | 213 |
| Operating capital generation | 119 | 130 |
Operating capital generation of Insurance Europe decreased to EUR 119 million from EUR 130 million in the first half of 2019, mainly reflecting a lower contribution from new business, which was impacted by lower sales due to COVID-19 restrictions as well as lower margins due to a decrease in interest rates.
The operating result decreased to EUR 133 million from EUR 140 million in the first half of 2019, which included a non-recurring benefit of EUR 6 million. Excluding this item, the operating result was broadly stable in the first half of 2020 reflecting a negative impact from COVID-19 of EUR 4 million, offset by higher life protection fees and higher pension fees in Romania.
The investment margin was broadly stable at EUR 48 million.
Fees and premium-based revenues increased to EUR 367 million from EUR 360 million in the first half of 2019, driven by higher life protection fees across the region as well as higher pension fees in Romania, partly offset by currency impacts across the region.
The technical margin increased to EUR 125 million from EUR 120 million in the first half of 2019, reflecting higher morbidity results across the region driven by COVID-19 restrictions, partly offset by unfavourable claims experience in Belgium.
Administrative expenses increased to EUR 214 million from EUR 206 million in the first half of 2019, mainly reflecting higher project expenses, partly offset by currency impacts across the region.
DAC amortisation and trail commissions increased to EUR 196 million from EUR 189 million in the first half of 2019, mainly due to portfolio growth.
The Non-life operating result decreased to EUR 2 million from EUR 5 million in the first half of 2019, which included a EUR 6 million non-recurring benefit.
The result before tax decreased to EUR 98 million from EUR 191 million in the first half of 2019, reflecting gains on the sale of government bonds and negative goodwill arising from the acquired Czech and Slovak businesses.
New sales (APE) decreased to EUR 319 million from EUR 348 million in the first half of 2019, mainly due to lower life and pension sales across the region due to COVID-19 restrictions, as well as negative currency impacts.
Value of new business decreased to EUR 84 million from EUR 108 million in the first half of 2019, reflecting the impact of lower sales and decreased interest rates.
Japan Life
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Investment margin | -8 | -7 |
| Fees and premium-based revenues | 364 | 366 |
| Technical margin | 8 | 7 |
| Operating income | 364 | 365 |
| Administrative expenses | 71 | 69 |
| DAC amortisation and trail commissions | 155 | 179 |
| Total expenses | 226 | 247 |
| Operating result | 138 | 118 |
| Non-operating items: | -32 | -18 |
| – of which gains/losses and impairments | -17 | -4 |
| – of which revaluations | -16 | -14 |
| Special items | -2 | -2 |
| Result before tax | 104 | 98 |
| Taxation | 29 | 28 |
| Net result | 75 | 70 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| New sales life insurance (APE) | 123 | 512 |
| Value of new business | 29 | 128 |
| Administrative expenses | 71 | 69 |
| Operating capital generation | 70 | 70 |
Value of new business of Japan Life was EUR 29 million, down from EUR 128 million in the first half of 2019 due to strong sales in the first quarter of 2019 ahead of the implementation of the revised tax regulations of COLI products, as well as COVID-19 restrictions in the first half of 2020.
Operating capital generation was stable at EUR 70 million, reflecting the positive impact of a lower new business strain as a result of lower sales following the revision of tax regulations of COLI products as well as COVID-19 restrictions in the first half of 2020, while the same period last year benefited from the impact of a reinsurance transaction.
Operating result was EUR 138 million, up 12.1% from the first half of 2019, excluding currency effects, reflecting improved persistency, partly offset by negative impact of COVID-19 of EUR 9 million.
Fees and premium-based revenues were EUR 364 million, down 4.9% from the first half of 2019, excluding currency effects, due to lower new business premiums following the revised regulations for the tax deductibility of COLI products which were introduced in July 2019, partly offset by increased persistency of the in-force portfolio.
Administrative expenses were EUR 71 million, down 1.2% from the first half of 2019, excluding currency effects.
DAC amortisation and trail commissions were EUR 155 million, down 17.2% from the first half of 2019, excluding currency effects, driven by lower new business premiums and lower surrenders reflecting increased persistency after the aforementioned tax rule change.
The result before tax was EUR 104 million, up 1.3% from the first half of 2019, excluding currency effects, reflecting higher operating result partly offset by impairments due to volatile markets as a result of COVID-19.
New sales (APE) were EUR 123 million, down 77.1% from the first half of 2019, excluding currency effects, reflecting strong sales in the first quarter of 2019, ahead of the implementation of the revised tax regulations of COLI products, as well as COVID-19 restrictions.
Analysis of results
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| Investment income | -1 | 1 |
| Fees | 216 | 215 |
| Operating income | 215 | 217 |
| Administrative expenses | 141 | 141 |
| Operating result | 74 | 76 |
| Non-operating items: | ||
| Special items | -6 | |
| Result before tax | 74 | 70 |
| Taxation | 19 | 16 |
| Minority interests | 2 | |
| Net result | 53 | 53 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| Administrative expenses | 141 | 141 |
| Operating capital generation | 50 | 62 |
| 31 December | ||
|---|---|---|
| amounts in billions of euros | 30 June 2020 | 2019 |
| Assets under Management | 285 | 276 |
Operating capital generation was EUR 50 million in the first half of 2020 mainly reflecting the net result, compared with EUR 62 million in the first half of 2019 which included non-recurring benefits.
Total Assets under Management (AuM) increased to EUR 285 billion at 30 June 2020 from EUR 276 billion at the end of 2019. The increase reflects positive market performance of EUR 4.7 billion, the inclusion of EUR 2.8 billion of assets related to VIVAT Non-life and Venn Hypotheken, as well as net inflows of EUR 1.5 billion. Positive market performance reflects the impact of the lower interest rates, mainly in Fixed Income and multi-asset strategies, partly offset by lower equity markets. The first half of 2020 saw net inflows in Third Party (EUR 3.5 billion) and Other Affiliates (EUR 0.2 billion), partly offset by net outflows in Proprietary (EUR 2.2 billion).
The operating result was broadly stable at EUR 74 million in the first half of 2020. The impact of COVID-19 was EUR -8 million due to the volatile markets which put pressure on fee income.
Fees were EUR 216 million, up from EUR 215 million in the first half of 2019. The increase reflects higher average AuM largely offset by a less favourable asset mix and fee pressure.
Administrative expenses remained stable at EUR 141 million compared with the first half of 2019.
The first half-year result before tax increased to EUR 74 million compared with EUR 70 million in the first half of 2019, driven by lower special items, partly offset by the lower operating result.
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Interest result | 140 | 127 |
| Commission income | 18 | 17 |
| Total investment and other income | 27 | 20 |
| Operating income | 185 | 164 |
| Operating expenses | 93 | 92 |
| Regulatory levies | 12 | 10 |
| Addition to loan loss provision | 2 | |
| Total expenses | 105 | 104 |
| Operating result | 80 | 60 |
| Non-operating items: | 1 | -3 |
| – of which gains/losses and impairments | 3 | 4 |
| – of which market and other impacts | -2 | -7 |
| Special items | -7 | -8 |
| Result before tax | 73 | 49 |
| Taxation | 19 | 13 |
| Net result | 54 | 35 |
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Total administrative expenses1 | 105 | 102 |
| Cost/income ratio2 | 50.1% | 56.4% |
| Net operating RoE3 | 15.0% | 11.6% |
| Operating capital generation | 0 | 56 |
| 31 December | ||
|---|---|---|
| amounts in billions of euros | 30 June 2020 | 2019 |
| Total assets | 25 | 25 |
1 Operating expenses plus regulatory levies.
2 Cost/income ratio is calculated as Operating expenses divided by Operating income.
3 Net operating RoE is calculated as the (annualised) net operating result of the segment, divided by (average) adjusted allocated equity. Adjusted allocated equity is an Alternative Performance Measure. It is derived from IFRS equity by excluding revaluation reserves. Reference is made to the section 'Alternative Performance measures (Non-GAAP measures)' in the NN Group N.V. 30 June 2020 Condensed consolidated interim financial information. As from 2H19, the average adjusted allocated equity is calculated based on the average of the adjusted allocated equity at the beginning and end of the half-year reporting period. Prior-period number was calculated on a quarterly basis and have not been restated.
Net operating Return on Equity (RoE) of Banking increased to 15.0% compared with 11.6% in the first half of 2019, reflecting a higher net operating result partly offset by higher equity.
Operating capital generation reflects the dividends of the segment to the holding and was nil in the first half of 2020 compared with EUR 56 million in the first half of 2019, due to the suspension of dividend payments in 2020 in accordance with the recommendation of the Dutch regulator.
The operating result increased to EUR 80 million from EUR 60 million in the first half of 2019, mainly driven by a higher interest result and higher investment and other income, which includes a EUR 7 million non-recurring benefit. The COVID-19 impact in the first half of 2020 was EUR -4 million reflecting higher operating expenses for acceptance processes and arrears management as well as higher additions to loan loss provisions.
The interest result increased to EUR 140 million from EUR 127 million in the first half of 2019, mainly reflecting lower funding costs and higher penalty interest on a higher volume of mortgage redemptions as well as lower mortgage rates. The net interest margin, calculated on a four quarter rolling average, remained broadly stable at 1.11% in the first half of 2020.
Commission income increased to EUR 18 million from EUR 17 million in the first half of 2019, driven by servicing fees on a larger mortgage portfolio.
Total investment and other income increased to EUR 27 million from EUR 20 million in the first half of 2019, mainly driven by a EUR 7 million nonrecurring benefit relating to premiums on mortgage sales to the NN IP Dutch Residential Mortgage Fund.
Operating expenses increased to EUR 93 million from EUR 92 million in the first half of 2019. Regulatory levies increased to EUR 12 million from EUR 10 million in the first half of 2019 reflecting the higher volume of savings.
Loan loss provisions were stable in the first half of 2020, reflecting higher provisions due to payment holidays granted to customers affected by COVID-19 offset by higher house prices.
The result before tax increased to EUR 73 million from EUR 49 million in the first half of 2019, mainly driven by the higher operating result and higher non-operating items.
Other
Analysis of results
| amounts in millions of euros | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Interest on hybrids and debt1 | -54 | -54 |
| Investment income and fees | 55 | 51 |
| Holding expenses | -79 | -81 |
| Holding result | -78 | -83 |
| Operating result reinsurance business | -25 | -5 |
| Other results | -1 | |
| Operating result | -104 | -88 |
| Non-operating items: | -2 | 1 |
| – of which gains/losses and impairments | -5 | 6 |
| – of which revaluations | 1 | -3 |
| – of which market and other impacts | 1 | -2 |
| Special items | -35 | -27 |
| Acquisition intangibles and goodwill | -13 | -16 |
| Result on divestments | 4 | |
| Result before tax | -155 | -126 |
| Taxation | -43 | -36 |
| Net result | -112 | -90 |
1 Does not include interest costs on subordinated debt treated as equity.
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in millions of euros | June 2020 | June 2019 |
| Total administrative expenses: | 83 | 84 |
| – of which reinsurance business | 4 | 3 |
| – of which corporate/holding | 79 | 81 |
| Operating capital generation | -133 | -111 |
Operating capital generation of the segment Other was EUR -133 million compared with EUR -111 million in the first half of 2019, which benefited from a reinsurance transaction with Japan Life, while first half of 2020 reflects higher claims related to Netherlands Non-life's Disability portfolio.
The operating result was EUR -104 million versus EUR -88 million in the first half of 2019, mainly reflecting a lower operating result of the reinsurance business, partly offset by a higher holding result. The impact of COVID-19 was EUR -5 million for the first half of the year, related to the reinsurance business.
The holding result improved to EUR -78 million from EUR -83 million in the first half of 2019, reflecting higher investment and interest income, as well as lower holding expenses.
The operating result of the reinsurance business decreased to EUR -25 million from EUR -5 million in the first half of 2019, mainly reflecting EUR 39 million of claims related to Non-life's Disability portfolio, while the same period in 2019 included EUR 13 million of claims related to Non-life's Disability portfolio as well as a large claim from a legacy reinsurance portfolio.
The result before tax of the segment Other decreased to EUR -155 million from EUR -126 million in the first half of 2019, mainly reflecting the lower operating result and higher special items.
Non-trading derivatives increased by EUR 6.2 billion in the first half of 2020 to EUR 16.4 billion, reflecting positive revaluations on derivatives used for hedging purposes driven by lower interest rates.
The Available-for-sale investments increased by EUR 0.6 billion in the first half of 2020 to EUR 118.2 billion driven by the decrease in interest rates and the addition of the assets of VIVAT Non-life, largely offset by reinvestments in loans.
Insurance and investment contracts increased by EUR 1.9 billion in the first half of 2020 to EUR 170.2 billion, mainly reflecting the addition of the insurance liabilities of VIVAT Non-life.
The increase of Other liabilities of EUR 5.4 billion in the first half of 2020 to EUR 18.6 billion mainly reflects higher cash collateral due to decreased interest rates.
Shareholders' equity increased by EUR 4.4 billion in the first half of 2020 to EUR 35.1 billion, reflecting positive revaluations driven by lower interest rates.
The Executive Board of NN Group N.V. is required to prepare the Interim report and Condensed consolidated interim accounts of NN Group N.V. in accordance with applicable Dutch law and International Financial Reporting Standards that are endorsed by the European Union (IFRS-EU).
The Executive Board of NN Group N.V. is responsible for maintaining proper accounting records, for safeguarding assets and for taking reasonable steps to prevent and detect fraud and other irregularities. It is responsible for selecting suitable accounting policies and applying them on a consistent basis, making judgements and estimates that are prudent and reasonable. It is also responsible for establishing and maintaining internal procedures which ensure that all major financial information is known to the Executive Board of NN Group N.V., so that the timeliness, completeness and correctness of the external financial reporting are assured. As required by section 5:25d paragraph 2(c) of the Dutch Financial Supervision Act, each of the signatories hereby confirms that to the best of his knowledge:
The Hague, 5 August 2020
David Knibbe CEO, Chair of the Executive Board
Delfin Rueda CFO, Vice-chair of the Executive Board
Amounts in millions of euros, unless stated otherwise
| 31 December | |||
|---|---|---|---|
| notes | 30 June 2020 | 2019 | |
| Assets | |||
| Cash and cash equivalents | 12,388 | 6,436 | |
| Financial assets at fair value through profit or loss: | 3 | ||
| – investments for risk of policyholders | 32,288 | 34,433 | |
| – non-trading derivatives | 16,431 | 10,189 | |
| – designated as at fair value through profit or loss | 1,344 | 1,184 | |
| Available-for-sale investments | 4 | 118,202 | 117,644 |
| Loans | 5 | 64,580 | 61,768 |
| Reinsurance contracts | 10 | 1,173 | 988 |
| Associates and joint ventures | 6 | 5,396 | 5,457 |
| Real estate investments | 2,561 | 2,571 | |
| Property and equipment | 471 | 465 | |
| Intangible assets | 7 | 1,093 | 995 |
| Deferred acquisition costs | 1,934 | 1,913 | |
| Deferred tax assets | 82 | 84 | |
| Other assets | 8 | 4,326 | 4,470 |
| Total assets | 262,269 | 248,597 | |
| Equity | |||
| Shareholders' equity (parent) | 35,117 | 30,768 | |
| Minority interests | 256 | 260 | |
| Undated subordinated notes | 1,764 | 1,764 | |
| Total equity | 9 | 37,137 | 32,792 |
| Liabilities | |||
| Subordinated debt | 2,396 | 2,409 | |
| Debt securities issued | 1,693 | 1,992 | |
| Other borrowed funds | 7,027 | 7,614 | |
| Insurance and investment contracts | 10 | 170,204 | 168,251 |
| Customer deposits and other funds on deposit | 15,598 | 15,161 | |
| Financial liabilities at fair value through profit or loss: | |||
| – non-trading derivatives | 4,480 | 3,232 | |
| Deferred tax liabilities | 5,185 | 4,030 | |
| Other liabilities | 11 | 18,549 | 13,116 |
| Total liabilities | 225,132 | 215,805 | |
| Total equity and liabilities | 262,269 | 248,597 |
References relate to the notes starting with Note 1 'Accounting policies'. These form an integral part of the Condensed consolidated interim accounts.
| notes | 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|---|---|---|
| Gross premium income | 7,751 | 7,819 |
| Investment income 12 |
2,130 | 2,131 |
| Result on disposals of group companies | 8 | |
| – gross fee and commission income | 504 | 517 |
| – fee and commission expenses | -149 | -173 |
| Net fee and commission income: | 355 | 344 |
| Valuation results on non-trading derivatives | 468 | 180 |
| Foreign currency results | -46 | -49 |
| Share of result from associates and joint ventures | 46 | 322 |
| Other income | 21 | 63 |
| Total income | 10,725 | 10,818 |
| – gross underwriting expenditure | 8,232 | 11,086 |
| – investment result for risk of policyholders | 712 | -3,066 |
| – reinsurance recoveries | -605 | -116 |
| Underwriting expenditure: 13 |
8,339 | 7,904 |
| Intangible amortisation and other impairments | 14 | 16 |
| Staff expenses | 784 | 789 |
| Interest expenses | 270 | 248 |
| Other operating expenses | 472 | 437 |
| Total expenses | 9,879 | 9,394 |
| Result before tax | 846 | 1,424 |
| Taxation | 249 | 296 |
| Net result | 597 | 1,128 |
| 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|
|---|---|---|
| Net result attributable to: | ||
| Shareholders of the parent | 587 | 1,118 |
| Minority interests | 10 | 10 |
| Net result | 597 | 1,128 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| amounts in euros | June 2020 | June 2019 |
| Earnings per ordinary share | ||
| Basic earnings per ordinary share | 1.77 | 3.26 |
| Diluted earnings per ordinary share | 1.76 | 3.26 |
Reference is made to Note 14 'Earnings per ordinary share' for the disclosure on the Earnings per ordinary share.
| 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|||
|---|---|---|---|---|
| Net result | 597 | 1,128 | ||
| – unrealised revaluations available-for-sale investments and other | 1,216 | 4,843 | ||
| – realised gains/losses transferred to the profit and loss account | -151 | -84 | ||
| – changes in cash flow hedge reserve | 3,749 | 3,859 | ||
| – deferred interest credited to policyholders | -739 | -1,707 | ||
| – share of other comprehensive income of associates and joint ventures | 4 | -5 | ||
| – exchange rate differences | -35 | 36 | ||
| Items that may be reclassified subsequently to the profit and loss account: | 4,044 | 6,942 | ||
| – remeasurement of the net defined benefit asset/liability | -1 | -37 | ||
| – unrealised revaluations property in own use | -1 | 4 | ||
| Items that will not be reclassified to the profit and loss account: | -2 | -33 | ||
| Total other comprehensive income | 4,042 | 6,909 | ||
| Total comprehensive income | 4,639 | 8,037 | ||
| Comprehensive income attributable to: | ||||
| Shareholders of the parent | 4,639 | 8,006 | ||
| Minority interests | 31 | |||
| Total comprehensive income | 4,639 | 8,037 |
| 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|
|---|---|---|
| Result before tax | 846 | 1,424 |
| Adjusted for: | ||
| – depreciation and amortisation | 80 | 71 |
| – deferred acquisition costs and value of business acquired | 1 | -178 |
| – underwriting expenditure (change in insurance liabilities) | 1,226 | -5 |
| – realised results and impairments of Available-for-sale investments | -172 | -103 |
| – other | 62 | 162 |
| Taxation paid (received) | -130 | -37 |
| Changes in: | ||
| – non-trading derivatives | 378 | 1,430 |
| – other financial assets at fair value through profit or loss | -146 | -518 |
| – loans | -2,609 | -1,855 |
| – other assets | 417 | -305 |
| – customer deposits and other funds on deposit | 449 | 468 |
| – financial liabilities at fair value through profit or loss – non-trading derivatives | -610 | -945 |
| – other liabilities | 5,169 | 3,245 |
| Net cash flow from operating activities | 4,961 | 2,854 |
| Investments and advances: | ||
| – group companies, net of cash acquired | -539 | -123 |
| – available-for-sale investments | -15,302 | -9,047 |
| – associates and joint ventures | -153 | -292 |
| – real estate investments | -52 | -68 |
| – property and equipment | -28 | -30 |
| – investments for risk of policyholders | -4,190 | -2,711 |
| – other investments | -30 | -131 |
| Disposals and redemptions: | ||
| – available-for-sale investments | 17,606 | 7,786 |
| – associates and joint ventures | 78 | 296 |
| – real estate investments | 30 | |
| – property and equipment | 1 | 2 |
| – investments for risk of policyholders | 4,772 | 3,267 |
| Net cash flow from investing activities | 2,193 | -1,051 |
| Proceeds from other borrowed funds | 3,380 | 1,945 |
| Repayments of other borrowed funds | -4,295 | -1,091 |
| Dividend paid | -253 | |
| Purchase/sale of treasury shares and warrants | -257 | -163 |
| Coupon on undated subordinated notes | -33 | -33 |
| Net cash flow from financing activities | -1,205 | 405 |
| Net cash flow | 5,949 | 2,208 |
| 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|
|---|---|---|
| Interest received | 2,438 | 2,472 |
| Interest paid | -318 | -301 |
| Dividend received | 344 | 308 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| June 2020 | June 2019 | |
| Cash and cash equivalents at beginning of the period | 6,436 | 8,886 |
| Net cash flow | 5,949 | 2,208 |
| Effect of exchange rate changes on cash and cash equivalents | 3 | 37 |
| Cash and cash equivalents at end of the period | 12,388 | 11,131 |
| Share capital |
Share premium |
Reserves | Total Shareholders' equity (parent) |
Minority interest |
Undated subordinated notes |
Total equity |
|
|---|---|---|---|---|---|---|---|
| Balance at 1 January 2020 | 41 | 12,572 | 18,155 | 30,768 | 260 | 1,764 | 32,792 |
| Unrealised revaluations available-for | |||||||
| sale investments and other | 1,226 | 1,226 | -10 | 1,216 | |||
| Realised gains/losses transferred to the | |||||||
| profit and loss account | -151 | -151 | -151 | ||||
| Changes in cash flow hedge reserve | 3,749 | 3,749 | 3,749 | ||||
| Deferred interest credited to | |||||||
| policyholders | -739 | -739 | -739 | ||||
| Share of other comprehensive income of | |||||||
| associates and joint ventures | 4 | 4 | 4 | ||||
| Exchange rate differences | -35 | -35 | -35 | ||||
| Remeasurement of the net defined | |||||||
| benefit asset/liability | -1 | -1 | -1 | ||||
| Unrealised revaluations property in own | |||||||
| use | -1 | -1 | -1 | ||||
| Total amount recognised directly in | |||||||
| equity (Other comprehensive income) | - | - | 4,052 | 4,052 | -10 | - | 4,042 |
| Net result for the period | 587 | 587 | 10 | 597 | |||
| Total comprehensive income | - | - | 4,639 | 4,639 | - | - | 4,639 |
| Changes in share capital | -3 | 3 | - | - | |||
| Dividend | -4 | -4 | |||||
| Purchase/sale of treasury shares | -258 | -258 | -258 | ||||
| Employee stock option and share plans | -1 | -1 | -1 | ||||
| Coupon on undated subordinated notes | -59 | -59 | -59 | ||||
| Changes in composition of the group | |||||||
| and other changes | 28 | 28 | 28 | ||||
| Balance at 30 June 2020 | 38 | 12,575 | 22,504 | 35,117 | 256 | 1,764 | 37,137 |
| Total Shareholders' |
Undated | ||||||
|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Reserves | equity (parent) |
Minority interest |
subordinated notes |
Total equity |
|
| Balance at 1 January 2019 | 41 | 12,572 | 10,237 | 22,850 | 234 | 1,764 | 24,848 |
| Unrealised revaluations available-for | |||||||
| sale investments and other | 4,822 | 4,822 | 21 | 4,843 | |||
| Realised gains/losses transferred to the | |||||||
| profit and loss account | -84 | -84 | -84 | ||||
| Changes in cash flow hedge reserve | 3,859 | 3,859 | 3,859 | ||||
| Deferred interest credited to | |||||||
| policyholders | -1,707 | -1,707 | -1,707 | ||||
| Share of other comprehensive income of | |||||||
| associates and joint ventures | -5 | -5 | -5 | ||||
| Exchange rate differences | 36 | 36 | 36 | ||||
| Remeasurement of the net defined | |||||||
| benefit asset/liability | -37 | -37 | -37 | ||||
| Unrealised revaluations property in own | |||||||
| use | 4 | 4 | 4 | ||||
| Total amount recognised directly in | |||||||
| equity (Other comprehensive income) | - | - | 6,888 | 6,888 | 21 | - | 6,909 |
| Net result for the period | 1,118 | 1,118 | 10 | 1,128 | |||
| Total comprehensive income | - | - | 8,006 | 8,006 | 31 | - | 8,037 |
| Dividend | -243 | -243 | -10 | -253 | |||
| Purchase/sale of treasury shares | -168 | -168 | -168 | ||||
| Employee stock option and share plans | -1 | -1 | -1 | ||||
| Coupon on undated subordinated notes | -59 | -59 | -59 | ||||
| Balance at 30 June 2019 | 41 | 12,572 | 17,772 | 30,385 | 255 | 1,764 | 32,404 |
The accounting principles used to prepare these Condensed consolidated interim accounts comply with International Financial Reporting Standards as adopted by the European Union (IFRS-EU) and are consistent with those set out in the notes to the 2019 NN Group Consolidated annual accounts, except as set out below.
In these Condensed consolidated interim accounts, 'NN Group' refers to NN Group N.V. (the parent company) and/or NN Group N.V. together with its consolidated subsidiaries (the consolidated group). These Condensed consolidated interim accounts should be read in conjunction with the 2019 NN Group Consolidated annual accounts.
IFRS-EU provides a number of options in accounting policies. NN Group's accounting policies under IFRS-EU and its decision on the options available are set out in Note 1 'Accounting policies' of the 2019 NN Group Consolidated annual accounts.
Certain amounts recorded in the Condensed consolidated interim accounts reflect estimates and assumptions made by management. Actual results may differ from the estimates made. Interim results are not necessarily indicative of full-year results.
Reference is made to the 2019 NN Group Consolidated annual accounts for more details on upcoming changes in accounting policies.
In September 2019, the IASB issued an amendment to IAS 39, IFRS 7 and IFRS 9 in relation to the interest rate benchmark reform. These amendments eliminate the impact, if any, of the interest rate benchmark reform on derivatives qualifying for hedge accounting under IFRS. The amendments are effective for NN Group as of 1 January 2020. Almost all hedge accounting applied by NN Group relates to interest rate risk based on Euribor. The calculation method of Euribor changed during 2019 and Euribor will continue to be used after the benchmark reform. As a result, NN Group expects that Euribor will continue to exist as a benchmark and does not anticipate replacing Euribor in its interest rate risk management and related hedge accounting. Therefore, the implementation of the amendments does not have an impact on NN Group.
As of 2020 NN Group changed its external reporting frequency from quarterly reporting to semi-annual reporting. The reporting frequency impacts the determination of certain impairments under IFRS, most notable impairments on investments in equity securities, as these are determined for the specific reporting period and cannot be reversed. Therefore such impairments are determined on a semi-annual basis as of 2020. This change does not impact the comparative figures for 2019.
As of 2020 NN Group changed its accounting for the Japan Closed Block VA portfolio, part of the reporting segment Other. Under the revised accounting, further elements of the portfolio are accounted for at fair value through profit or loss in order to better align with the accounting of the related hedging derivatives. The impact of this change as at 1 January 2020, which was not material for NN Group, is included directly in shareholders' equity.
Since early 2020, the spread of the COVID-19 pandemic is causing significant disruption to society and the world-wide economy, impacting NN Group, its employees, its customers and its suppliers. Financial markets have been severely impacted by significant decreases in interest rates, equity prices and spread widening and the world-wide economy has been significantly impacted as well. Governments and central banks worldwide are responding to this crisis with aid packages and further supporting measures. At the date of this report, the depth and length of this crisis is unknown. NN Group is constantly monitoring the developments and the (potential) impact on NN Group. The most significant risks that NN Group is facing in this context are related to the financial markets (including interest rates, equity prices and spreads), insurance risk (including mortality and policyholder behaviour) and operational risk (continuity of business processes). The notes to the 2019 annual accounts include extensive disclosure on the exposure to such risks and the risk management thereof; these disclosures remain valid.
The COVID-19 pandemic, and the related impact on the financial markets, impacted the results of NN Group in the first half of 2020 mainly in the following areas:
In the first half of 2020, there were no significant impairments of other assets (including debt securities, loans and intangible assets). Furthermore, there was no significant impact from the COVID-19 pandemic on the technical provisions for insurance contracts.
At the date of this report, it is too early to determine the structural impact of the COVID-19 pandemic on results, capitalisation and longer term assumptions, if any. Also the amount and profitability of new sales may be impacted but, at the date of this report, it is too early to assess any (potential) structural impact.
NN Group has established a business continuity plan to help ensure the continuity of its businesses, the well-being of its staff and its capability to support its customers, whilst maintaining financial and operations resilience.
Financial assets at fair value through profit or loss
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Investments for risk of policyholders | 32,288 | 34,433 |
| Non-trading derivatives | 16,431 | 10,189 |
| Designated as at fair value through profit or loss | 1,344 | 1,184 |
| Financial assets at fair value through profit or loss | 50,063 | 45,806 |
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Equity securities | 29,317 | 31,534 |
| Debt securities | 1,679 | 1,695 |
| Loans and receivables | 1,292 | 1,204 |
| Investments for risk of policyholders | 32,288 | 34,433 |
Investments in investment funds (with underlying investments in debt and equity securities, real estate and derivatives) are included in equity securities.
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Derivatives used in: | ||
| – fair value hedges | 6 | 52 |
| – cash flow hedges | 12,011 | 7,365 |
| – hedges of net investments in foreign operations | 10 | |
| Other non-trading derivatives | 4,404 | 2,772 |
| Non-trading derivatives | 16,431 | 10,189 |
Other non-trading derivatives includes derivatives for which no hedge accounting is applied.
Designated as at fair value through profit or loss
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Equity securities | 419 | 333 |
| Debt securities | 39 | 31 |
| Money market funds | 886 | 820 |
| Designated as at fair value through profit or loss | 1,344 | 1,184 |
The increase in Available-for-sale investments from EUR 117,644 million as at 31 December 2019 to EUR 118,202 million as at 30 June 2020 includes EUR 1,517 million recognised on the acquisition of VIVAT Non-life. For more information reference is made to Note 18 'Companies and businesses acquired and divested'.
Available-for-sale investments
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Equity securities: | ||
| – shares in NN Group managed investment funds | 2,374 | 2,096 |
| – shares in third-party managed investment funds | 1,840 | 1,552 |
| – other | 5,028 | 4,430 |
| Equity securities | 9,242 | 8,078 |
| Debt securities | 108,960 | 109,566 |
| Available-for-sale investments | 118,202 | 117,644 |
NN Group's total exposure to debt securities is included in the following balance sheet lines:
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Available-for-sale investments | 108,960 | 109,566 |
| Loans | 1,133 | 1,251 |
| Available-for-sale investments and loans | 110,093 | 110,817 |
| Investments for risk of policyholders | 1,679 | 1,695 |
| Designated as at fair value through profit or loss | 39 | 31 |
| Financial assets at fair value through profit or loss | 1,718 | 1,726 |
| Total exposure to debt securities | 111,811 | 112,543 |
NN Group's total exposure to debt securities included in 'Available-for-sale investments' and 'Loans' is specified as follows by type of exposure:
Debt securities by type
| Available-for-sale investments | Loans | Total | ||||
|---|---|---|---|---|---|---|
| 31 December | 31 December | 31 December | ||||
| 30 June 2020 | 2019 | 30 June 2020 | 2019 | 30 June 2020 | 2019 | |
| Government bonds | 71,639 | 74,271 | 71,639 | 74,271 | ||
| Corporate bonds | 20,977 | 19,024 | 20,977 | 19,024 | ||
| Financial institution and Covered bonds | 12,829 | 13,318 | 12,829 | 13,318 | ||
| Bond portfolio (excluding ABS) | 105,445 | 106,613 | - | - | 105,445 | 106,613 |
| US RMBS | 563 | 552 | 563 | 552 | ||
| Non-US RMBS | 2,419 | 1,987 | 1,039 | 1,138 | 3,458 | 3,125 |
| CDO/CLO | 6 | 6 | 6 | 6 | ||
| Other ABS | 527 | 408 | 94 | 113 | 621 | 521 |
| ABS portfolio | 3,515 | 2,953 | 1,133 | 1,251 | 4,648 | 4,204 |
| Debt securities – Available-for-sale investments | ||||||
| and Loans | 108,960 | 109,566 | 1,133 | 1,251 | 110,093 | 110,817 |
Loans
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Loans secured by mortgages | 54,195 | 51,382 |
| Loans related to savings mortgages | 1,605 | 1,672 |
| Loans to or guaranteed by public authorities | 1,900 | 1,879 |
| Asset-backed securities | 1,133 | 1,251 |
| Policy loans | 967 | 666 |
| Other loans | 4,907 | 5,040 |
| Loans – before loan loss provisions | 64,707 | 61,890 |
| Loan loss provisions | -127 | -122 |
| Loans | 64,580 | 61,768 |
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Loan loss provisions – opening balance | 122 | 167 |
| Write-offs | -1 | -52 |
| Recoveries | 1 | |
| Increase/decrease in loan loss provisions | 5 | 11 |
| Changes in the composition of the group and other changes | -4 | |
| Loan loss provisions – closing balance | 127 | 122 |
Associates and joint ventures
| Interest held |
Balance sheet value |
Interest held |
Balance sheet value |
|
|---|---|---|---|---|
| 31 December | ||||
| 30 June 2020 | 2019 | |||
| Vesteda Residential Fund FGR | 24% | 1,505 | 24% | 1,467 |
| CBRE Dutch Office Fund FGR | 19% | 360 | 19% | 361 |
| CBRE Retail Property Fund Iberica L.P. | 50% | 233 | 50% | 265 |
| CBRE European Industrial Fund C.V. | 25% | 218 | 19% | 151 |
| CBRE Dutch Retail Fund FGR | 20% | 207 | 20% | 218 |
| CBRE Dutch Residential Fund FGR | 10% | 204 | 10% | 200 |
| Lazora S.I.I. S.A. | 22% | 203 | 22% | 205 |
| NRP Nordic Logistic Fund AS | 42% | 192 | 42% | 190 |
| CBRE UK Property Fund PAIF | 10% | 161 | 10% | 182 |
| Allee center Kft | 50% | 129 | 50% | 129 |
| Achmea Dutch Health Care Property Fund | 24% | 122 | 27% | 119 |
| Dutch Student and Young Professional Housing fund FGR | 49% | 116 | 49% | 113 |
| Robeco Bedrijfsleningen FGR | 26% | 114 | 26% | 112 |
| Parcom Buy-Out Fund V CV | 21% | 99 | 21% | 96 |
| Fiumaranuova s.r.l. | 50% | 99 | 50% | 101 |
| Siresa House S.L. | 49% | 91 | 49% | 96 |
| Boccaccio - Closed-end Real Estate Mutual Investment Fund | 50% | 89 | 50% | 93 |
| The Fizz Student Housing Fund SCS | 50% | 84 | 50% | 83 |
| Dutch Urban Living Venture FGR | 42% | 77 | 42% | 71 |
| DPE Deutschland II B GmbH & Co KG | 35% | 76 | 35% | 117 |
| Parcom Buy Out Fund IV B.V. | 100% | 74 | 100% | 89 |
| CBRE Dutch Retail Fund II FGR | 10% | 71 | 10% | 74 |
| Rivage Euro Debt infrastructure 3 | 34% | 64 | 34% | 40 |
| DPE Deutschland III (Parallel) GmbH & Co | 17% | 63 | 17% | 56 |
| CBRE Property Fund Central and Eastern Europe FGR | 50% | 60 | 50% | 62 |
| Delta Mainlog Holding GmbH & Co. KG | 50% | 59 | 50% | 61 |
| Parquest Capital II B FPCI | 29% | 56 | 29% | 53 |
| Other | 570 | 653 | ||
| Associates and joint ventures | 5,396 | 5,457 |
The above associates and joint ventures mainly consist of non-listed investment entities investing in real estate and private equity.
Significant influence exists for certain associates in which the interest held is below 20%, based on the combination of NN Group's financial interest for own risk and other arrangements, such as participation in the relevant boards.
NN Group holds associates over which it cannot exercise control despite holding more than 50% of the share capital. For this reason, these are classified as associates and are not consolidated.
Other includes EUR 377 million (31 December 2019: EUR 468 million) of associates and joint ventures with an individual balance sheet value of less than EUR 50 million (in current year) and EUR 193 million (31 December 2019: EUR 185 million) of receivables from associates and joint ventures.
The amounts presented in the table above could differ from the individual annual accounts of the associates due to the fact that the individual amounts have been brought in line with NN Group's accounting principles.
Intangible assets
| 31 December | |
|---|---|
| 30 June 2020 | 2019 |
| 536 | 539 |
| 244 | 149 |
| 84 | 79 |
| 229 | 228 |
| 1,093 | 995 |
Value of business acquired relates to the acquisition of VIVAT Non-life in 2020 and the acquisitions in the Czech Republic and Slovakia in 2019. Reference is made to Note 18 'Companies and businesses acquired and divested'.
| 31 December | |
|---|---|
| 30 June 2020 | 2019 |
| 928 | 824 |
| 56 | 29 |
| 1,226 | 1,512 |
| 171 | 258 |
| 1,330 | 1,326 |
| 615 | 521 |
| 4,326 | 4,470 |
Total equity
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Share capital | 38 | 41 |
| Share premium | 12,575 | 12,572 |
| Revaluation reserve | 19,333 | 15,269 |
| Currency translation reserve | -3 | 3 |
| Net defined benefit asset/liability remeasurement reserve | -145 | -144 |
| Other reserves | 3,319 | 3,027 |
| Shareholders' equity (parent) | 35,117 | 30,768 |
| Minority interests | 256 | 260 |
| Undated subordinated notes | 1,764 | 1,764 |
| Total equity | 37,137 | 32,792 |
| Total shareholders' |
||||
|---|---|---|---|---|
| Share capital |
Share premium |
Reserves | equity (parent) |
|
| Equity – opening balance | 41 | 12,572 | 18,155 | 30,768 |
| Total amount recognised directly in equity (Other comprehensive income) | 4,052 | 4,052 | ||
| Net result for the period | 587 | 587 | ||
| Changes in share capital | -3 | 3 | - | |
| Purchase/sale of treasury shares | -258 | -258 | ||
| Employee stock option and share plans | -1 | -1 | ||
| Coupon on undated subordinated notes | -59 | -59 | ||
| Changes in the composition of the group and other changes | 28 | 28 | ||
| Equity – closing balance | 38 | 12,575 | 22,504 | 35,117 |
There was no final dividend for 2019. For more information reference is made to Note 19 'Other events'.
NN Group will pay an interim dividend of EUR 2.26 per ordinary share, or approximately EUR 705 million in total. This amount comprises (i) EUR 1.40 per ordinary share, equal to the amount of the 2019 final dividend that was suspended in April 2020 plus (ii) EUR 0.86 per ordinary share, equal to the regular 2020 interim dividend calculated in accordance with the NN Group dividend policy. The interim dividend will be paid either in cash, after deduction of withholding tax if applicable, or ordinary shares from the share premium reserve at the election of the shareholder. To neutralise the dilutive effect of the stock dividend, NN Group will repurchase ordinary shares for an amount equivalent to the stock dividend. The NN Group ordinary shares will be quoted ex-dividend on 10 August 2020. The record date for the dividend will be 11 August 2020. The election period will run from 12 August up to and including 26 August 2020. The stock fraction for the stock dividend will be based on the volume weighted average price of NN Group ordinary shares on Euronext Amsterdam for the five trading days from 20 August through 26 August 2020. The dividend will be payable on 2 September 2020. The interim dividend is deducted from Solvency II Own Funds at 30 June 2020. It is reflected in shareholders' equity under IFRS in the second half of 2020.
During the first half of 2020, treasury shares for a total amount of EUR 4 million were delivered under Employee share plans. Also 10,496,227 ordinary shares for a total amount of EUR 262 million were repurchased under the open market share buyback programme. As at 30 June 2020, 8,510,072 treasury shares were held by NN Group. For more information on the 2020 share buyback programme, refer to Note 19 'Other events'.
In the first half of 2020, 23,289,558 treasury shares were cancelled.
The undated subordinated notes have optional annual coupon payments in June and July. As a result of the share buyback programme, the 2020 coupon became mandatory and therefore the full annual coupon of EUR 59 million (net of tax) was deducted from equity in the first half of 2020.
| Share capital |
Share premium |
Reserves | Total shareholders' equity (parent) |
|
|---|---|---|---|---|
| Equity – opening balance | 41 | 12,572 | 10,237 | 22,850 |
| Total amount recognised directly in equity (Other comprehensive income) | 7,077 | 7,077 | ||
| Net result for the period | 1,962 | 1,962 | ||
| Dividend | -387 | -387 | ||
| Purchase/sale of treasury shares | -707 | -707 | ||
| Employee stock option and share plans | 2 | 2 | ||
| Coupon on undated subordinated notes | -59 | -59 | ||
| Changes in the composition of the group and other changes | 30 | 30 | ||
| Equity – closing balance | 41 | 12,572 | 18,155 | 30,768 |
In 2019, 20,996,349 ordinary shares for a total amount of EUR 712 million were repurchased under an open market share buyback programme, including repurchases to neutralise the dilutive effect of stock dividends. Treasury shares for an amount of EUR 5 million were delivered under Employee share plans. The repurchased shares are held by NN Group and the amount was deducted from Other reserves (Purchase/sale of treasury shares).
In 2019, 5,850,000 NN Group treasury shares were cancelled.
As at 31 December 2019, 21,485,285 treasury shares were held by NN Group.
In 2019, 4,807,859 NN Group shares were issued for the final dividend and 3,539,191 NN Group shares were issued for the interim dividend for the shareholders that opted to receive a stock dividend.
The undated subordinated notes have optional annual coupon payments in June and July. The annual coupons resulted in a deduction of EUR 59 million (net of tax) from equity.
NN Group owns 51% of the shares of ABN AMRO Verzekeringen Holding B.V. (ABN AMRO Verzekeringen). ABN AMRO Verzekeringen's principal place of business is Zwolle, the Netherlands. ABN AMRO Verzekeringen is fully consolidated by NN Group, with a minority interest recognised of 49%.
At 30 June 2020, the minority interest relating to ABN AMRO Verzekeringen recognised in equity was EUR 240 million (31 December 2019: EUR 241 million).
Summarised information ABN AMRO Verzekeringen1
| 31 December | ||
|---|---|---|
| 30 June 2020 | 20192 | |
| Total assets | 4,699 | 4,867 |
| Total liabilities | 4,210 | 4,375 |
| Total income | 288 | 561 |
| Total expenses | 267 | 503 |
| Net result recognised in period | 15 | 42 |
| Other comprehensive income recognised in period | -18 | 46 |
| Dividends paid | 0 | 49 |
1 All on 100% basis.
2 Total income, Total expenses, Net result recognised in period and Dividend paid are for the full year 2019.
The increase in Insurance and investment contracts, reinsurance contracts from EUR 167,263 million as at 31 December 2019 to EUR 169,031 million as at 30 June 2020 includes EUR 1,266 million Insurance and investment contracts and EUR 70 million reinsurance contracts recognised on the acquisition of VIVAT Non-life. For more information reference is made to Note 18 'Companies and businesses acquired and divested'.
| Liabilities net | Reinsurance | Insurance and | ||||
|---|---|---|---|---|---|---|
| of reinsurance | contracts | investment contracts | ||||
| 31 December | 31 December | 31 December | ||||
| 30 June 2020 | 2019 | 30 June 2020 | 2019 | 30 June 2020 | 2019 | |
| Life insurance liabilities excluding liabilities for risk of | ||||||
| policyholders | 128,335 | 126,089 | 716 | 679 | 129,051 | 126,768 |
| Liabilities for life insurance for risk of policyholders | 30,916 | 32,979 | 33 | 34 | 30,949 | 33,013 |
| Investment contract with discretionary participation | ||||||
| features for risk of policyholders | 227 | 245 | 227 | 245 | ||
| Life insurance liabilities | 159,478 | 159,313 | 749 | 713 | 160,227 | 160,026 |
| Liabilities for unearned premiums and unexpired risks | 890 | 390 | 27 | 15 | 917 | 405 |
| Claims liabilities | 6,499 | 5,400 | 397 | 260 | 6,896 | 5,660 |
| Insurance liabilities and investment contracts with | ||||||
| discretionary participation features | 166,867 | 165,103 | 1,173 | 988 | 168,040 | 166,091 |
| Investment contracts liabilities | 2,164 | 2,160 | 2,164 | 2,160 | ||
| Insurance and investment contracts, reinsurance | ||||||
| contracts | 169,031 | 167,263 | 1,173 | 988 | 170,204 | 168,251 |
The liabilities for insurance and investment contracts are presented gross in the balance sheet as 'Insurance and investment contracts'. The related reinsurance is presented as 'Reinsurance contracts' under Assets in the balance sheet.
In May 2020, NN Group entered into three reinsurance agreements to reinsure the full longevity risk associated with in total approximately EUR 13.5 billion of pension liabilities in NN Life in the Netherlands. This reinsurance reduces NN Group's exposure to longevity risk and, consequently, the required capital under Solvency II. The three reinsurance agreements are similar in nature but are agreed with three different assuming reinsurers, Canada Life, Munich Re and Swiss Re. The risk transfer is effective as of 1 January 2020 and will continue until the relevant portfolio has run off.
The relevant portfolio continues to be included in the Life insurance provisions in the IFRS balance sheet. There is no impact from the reinsurance on the recognition and measurement of the life insurance provisions in the balance sheet. NN Group will recognise premiums due to the reinsurers in Reinsurance and retrocession premiums and will recognise recoveries from the reinsurers in Reinsurance recoveries, both part of Underwriting expenditure in the profit and loss account. Reinsurance premiums and recoveries are settled with the reinsurers on an annual basis. In addition, a reinsurance asset is recognised under Reinsurance contracts for any reinsurance share of the underlying insurance liability based on NN Group's accounting policies for insurance contracts under IFRS. As at 30 June 2020 the reinsurance asset was nil. The reinsurance does not impact NN Group's liabilities towards its policyholders; to the extent that the assuming reinsurers would be unable to meet their obligations, NN Group remains liable to its policyholders for the portion reinsured. Consequently, provisions will be made for receivables on reinsurance contracts which are deemed uncollectable if and when relevant; no provision was recognised at 30 June 2020. There is no impact on the Reserve Adequacy Test, which is performed on the insurance liability gross of reinsurance.
The best estimate of all premiums and benefits due under the reinsurance are directly reflected in Solvency II Own Funds. The reduction of the longevity risk is reflected in a lower Solvency Capital Requirement. In combination, the lower risk profile resulted in an increase in the Solvency II ratio of NN Group of approximately 17%-points at the announcement of the reinsurance.
The premium payable to the assuming reinsurers is fixed and includes a margin of approximately EUR 451 million over the current best estimate of benefits payable under the related portfolios. This margin, which represents a cost of reinsurance to NN Group is recognised in the profit and loss account over the duration of the reinsurance. An amount of EUR 14 million was recognised in Underwriting expenditure in the profit and loss account in the current reporting period. An amount of approximately EUR 437 million (undiscounted) remains to be recognised in future periods.
Other liabilities
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Income tax payable | 167 | 83 |
| Net defined benefit liability | 202 | 175 |
| Other post-employment benefits | 16 | 17 |
| Other staff-related liabilities | 98 | 106 |
| Other taxation and social security contributions | 188 | 133 |
| Deposits from reinsurers | 328 | 321 |
| Lease liabilities | 353 | 345 |
| Accrued interest | 209 | 245 |
| Costs payable | 319 | 289 |
| Amounts payable to policyholders | 1,083 | 1,052 |
| Provisions | 285 | 292 |
| Amounts to be settled | 1,155 | 1,290 |
| Cash collateral amounts received | 13,006 | 7,978 |
| Other | 1,140 | 790 |
| Other liabilities | 18,549 | 13,116 |
| 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|
|---|---|---|
| Interest income from investments in debt securities | 886 | 890 |
| Interest income from loans | 811 | 789 |
| Interest income from investments in debt securities and loans | 1,697 | 1,679 |
| Realised gains/losses on disposal of available-for-sale debt securities | 402 | 96 |
| Impairments of available-for-sale debt securities | -5 | |
| Realised gains/losses and impairments of available-for-sale debt securities | 397 | 96 |
| Realised gains/losses on disposal of available-for-sale equity securities | 87 | 32 |
| Impairments of available-for-sale equity securities | -312 | -25 |
| Realised gains/losses and impairments of available-for-sale equity securities | -225 | 7 |
| Interest income on non-trading derivatives | 114 | 106 |
| Increase/decrease in loan loss provisions | -5 | -14 |
| Income from real estate investments | 57 | 49 |
| Dividend income | 127 | 203 |
| Change in fair value of real estate investments | -32 | 5 |
| Investment income | 2,130 | 2,131 |
Impairments on investments by segment
| 1 January to 30 | 1 January to 30 |
|---|---|
| June 2020 | June 2019 |
| Netherlands Life -261 |
-21 |
| Netherlands Non-life -23 |
-1 |
| Insurance Europe -2 |
-3 |
| Japan Life -17 |
|
| Other -14 |
|
| Impairments on investments -317 |
-25 |
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| June 2020 | June 2019 | |
| Gross underwriting expenditure: | ||
| – before effect of investment result for risk of policyholders | 8,944 | 8,020 |
| – effect of investment result for risk of policyholders | -712 | 3,066 |
| Gross underwriting expenditure | 8,232 | 11,086 |
| Investment result for risk of policyholders | 712 | -3,066 |
| Reinsurance recoveries | -605 | -116 |
| Underwriting expenditure | 8,339 | 7,904 |
The investment income and valuation results regarding investments for risk of policyholders is recognised in 'Underwriting expenditure'. As a result, it is shown together with the equal amount of related change in insurance liabilities for risk of policyholders. Reference is made to Note 10 'Insurance and investment contracts, reinsurance contracts'.
Reference is made to Note 10 'Insurance and investment contracts, reinsurance contracts' for the new longevity reinsurance transactions in 2020.
| 1 January to 30 June 2020 |
1 January to 30 June 2019 |
|
|---|---|---|
| Expenditure from life underwriting: | ||
| – reinsurance and retrocession premiums | 627 | 153 |
| – gross benefits | 5,920 | 6,195 |
| – reinsurance recoveries | -562 | -74 |
| – change in life insurance liabilities | 42 | -550 |
| – costs of acquiring insurance business | 272 | 282 |
| – other underwriting expenditure | 98 | 88 |
| – profit sharing and rebates | 39 | 31 |
| Expenditure from life underwriting | 6,436 | 6,125 |
| Expenditure from non-life underwriting: | ||
| – reinsurance and retrocession premiums | 115 | 79 |
| – gross claims | 1,099 | 981 |
| – reinsurance recoveries | -43 | -42 |
| – changes in the liabilities for unearned premiums | 338 | 399 |
| – changes in claims liabilities | 73 | 82 |
| – costs of acquiring insurance business | 314 | 278 |
| – other underwriting expenditure | -17 | -10 |
| Expenditure from non-life underwriting | 1,879 | 1,767 |
| Expenditure from investment contracts: | ||
| – costs of acquiring investment contracts | 1 | |
| – other changes in investment contract liabilities | 24 | 11 |
| Expenditure from investment contracts | 24 | 12 |
| Underwriting expenditure | 8,339 | 7,904 |
Earnings per ordinary share shows earnings per share amounts for profit or loss attributable to shareholders of the parent. Earnings per ordinary share is calculated on the basis of the weighted average number of ordinary shares outstanding. In calculating the weighted average number of ordinary shares outstanding, own shares held by group companies are deducted from the total number of ordinary shares in issue.
| Weighted average | ||||||
|---|---|---|---|---|---|---|
| Amounts | number of ordinary shares | Per ordinary share | ||||
| (in millions of euros) | (in millions) | (in euros) | ||||
| 1 January to 30 | 1 January to 30 | 1 January to 30 | 1 January to 30 | 1 January to 30 | 1 January to 30 | |
| June 2020 | June 2019 | June 2020 | June 2019 | June 2020 | June 2019 | |
| Net result | 587 | 1,118 | ||||
| Coupon on undated subordinated notes | -29 | -29 | ||||
| Basic earnings per ordinary share | 558 | 1,089 | 315.7 | 333.6 | 1.77 | 3.26 |
| Dilutive instruments: | ||||||
| – Share plans | 0.4 | 0.4 | ||||
| Dilutive instruments | 0.4 | 0.4 | ||||
| Diluted earnings per ordinary share | 558 | 1,089 | 316.1 | 334.0 | 1.76 | 3.26 |
Diluted earnings per share is calculated as if the share plans and warrants outstanding at the end of the period had been exercised at the beginning of the period and assuming that the cash received from exercised share plans and warrants was used to buy own shares against the average market price during the period. The net increase in the number of shares resulting from exercising share plans and warrants is added to the average number of shares used for the calculation of diluted earnings per share.
The reporting segments for NN Group, based on the internal reporting structure, are as follows:
The Executive Board and the Management Board set the performance targets and approve and monitor the budgets prepared by the reporting segments. The segments formulate strategic, commercial and financial policies in conformity with the strategy and performance targets set by the Executive Board and the Management Board.
The accounting policies of the segments are the same as those described in Note 1 'Accounting policies'. Transfer prices for inter-segment transactions are set at arm's length. Corporate expenses are allocated to segments based on time spent by head office personnel, the relative number of staff, or on the basis of income and/or assets of the segment. Intercompany loans that qualify as equity instruments under IFRS-EU are presented in the segment reporting as debt; related coupon payments are presented as income and expenses in the respective segments.
Segments (2020)
| Netherlands | Netherlands | Insurance | Asset | Total | ||||
|---|---|---|---|---|---|---|---|---|
| 1 January to 30 June 2020 | Life | Non-life | Europe | Japan Life | Management | Banking | Other | segments |
| Investment margin | 433 | 48 | -8 | -1 | 473 | |||
| Fees and premium-based revenues | 201 | 367 | 364 | 216 | 1,148 | |||
| Technical margin | 98 | 125 | 8 | 230 | ||||
| Operating income non-modelled life | ||||||||
| business | 1 | 1 | ||||||
| Operating income | 731 | - | 541 | 364 | 215 | - | - | 1,852 |
| Administrative expenses | 221 | 214 | 71 | 141 | 647 | |||
| DAC amortisation and trail commissions | 17 | 196 | 155 | 368 | ||||
| Expenses | 237 | - | 410 | 226 | 141 | - | - | 1,015 |
| Operating result non-life | 111 | 2 | 113 | |||||
| Operating result banking | 80 | 80 | ||||||
| Operating result other | -104 | -104 | ||||||
| Operating result | 494 | 111 | 133 | 138 | 74 | 80 | -104 | 926 |
| Non-operating items: | ||||||||
| – gains/losses and impairments | 211 | -24 | -1 | -17 | 3 | -5 | 168 | |
| – revaluations | 212 | -16 | -14 | -16 | 1 | 167 | ||
| – market and other impacts | -274 | 4 | -7 | -2 | 1 | -278 | ||
| Special items before tax | -32 | -35 | -13 | -2 | -7 | -35 | -123 | |
| Acquisition intangibles and goodwill | -13 | -13 | ||||||
| Result before tax | 612 | 40 | 98 | 104 | 74 | 73 | -155 | 846 |
| Taxation | 192 | 10 | 24 | 29 | 19 | 19 | -43 | 249 |
| Minority interests | 7 | 2 | 10 | |||||
| Net result | 413 | 30 | 74 | 75 | 53 | 54 | -112 | 587 |
Segments (2019)
| Netherlands | Netherlands | Insurance | Asset | Total | ||||
|---|---|---|---|---|---|---|---|---|
| 1 January to 30 June 2019 | Life | Non-life | Europe | Japan Life | Management | Banking | Other | segments |
| Investment margin | 482 | 49 | -7 | 1 | 525 | |||
| Fees and premium-based revenues | 209 | 360 | 366 | 215 | 1,150 | |||
| Technical margin | 81 | 120 | 7 | 207 | ||||
| Operating income non-modelled life | ||||||||
| business | 1 | 1 | ||||||
| Operating income | 772 | - | 530 | 365 | 217 | - | - | 1,883 |
| Administrative expenses | 230 | 206 | 69 | 141 | 646 | |||
| DAC amortisation and trail commissions | 17 | 189 | 179 | 386 | ||||
| Expenses | 248 | - | 396 | 247 | 141 | - | - | 1,031 |
| Operating result non-life | 84 | 5 | 90 | |||||
| Operating result banking | 60 | 60 | ||||||
| Operating result other | -88 | -88 | ||||||
| Operating result | 524 | 84 | 140 | 118 | 76 | 60 | -88 | 914 |
| Non-operating items: | ||||||||
| – gains/losses and impairments | 15 | 8 | 65 | -4 | 4 | 6 | 94 | |
| – revaluations | 614 | 4 | -28 | -14 | -3 | 573 | ||
| – market and other impacts | -64 | -1 | -7 | -2 | -75 | |||
| Special items before tax | -20 | -26 | -17 | -2 | -6 | -8 | -27 | -108 |
| Acquisition intangibles and goodwill | 33 | -16 | 17 | |||||
| Result on divestments | 5 | 4 | 8 | |||||
| Result before tax | 1,073 | 70 | 191 | 98 | 70 | 49 | -126 | 1,424 |
| Taxation | 224 | 15 | 36 | 28 | 16 | 13 | -36 | 296 |
| Minority interests | 5 | 5 | 10 | |||||
| Net result | 844 | 50 | 156 | 70 | 53 | 35 | -90 | 1,118 |
Special items in 2020 and 2019 mainly relate to restructuring expenses incurred in respect of the cost reduction target as well as expenses related to the VIVAT acquisition.
NN Group uses three Alternative Performance Measures (APMs, also referred to as Non-GAAP measures) in its external financial reporting: Operating result, Adjusted allocated equity and Administrative expenses.
Operating result (before tax) is used by NN Group to evaluate the financial performance of its segments. Each segment's operating result is calculated by adjusting the reported result before tax for the following items:
The operating result for the life insurance business is analysed through a margin analysis, which includes the investment margin, fees and premium-based revenues and the technical margin. Disclosures on comparative years also reflect the impact of current year's divestments. Operating result as presented below is an Alternative Performance Measure (non-GAAP financial measure) and is not a measure of financial performance under IFRS-EU. Because it is not determined in accordance with IFRS-EU, operating result as presented by NN Group may not be comparable to other similarly titled measures of performance of other companies. The net result on transactions between segments is eliminated in the net result of the relevant segment.
NN Group evaluates the efficiency of the operational deployment of its equity by calculating Return on Equity (RoE). The net operating RoE is calculated using Net operating result in the numerator and average Adjusted allocated equity in the denominator. Net operating result of NN Group is the Net operating result, adjusted to reflect the deduction of the accrued coupon on undated subordinated notes classified in equity. Adjusted allocated equity is derived from IFRS equity by adjusting for:
Allocated equity per segment represents the part of equity that is economically deployed by the segments. This allocation does not impact equity in total for NN Group. Adjusted allocated equity is an Alternative Performance Measure that is not a measure under IFRS-EU. Adjusted allocated equity as applied by NN Group may not be comparable to other similarly titled measures of other companies. Adjusted allocated equity is reconciled to IFRS Total equity as follows:
| 1 January to 30 | 31 December | |
|---|---|---|
| June 2020 | 2019 | |
| IFRS Total equity | 37,137 | 32,792 |
| Revaluation reserves, Goodwill and Intangible assets recognised upon acquisitions | -19,768 | -15,742 |
| Undated subordinated notes | -1,764 | -1,764 |
| Adjusted allocated equity | 15,605 | 15,286 |
NN Group monitors the level of expenses and assesses cost savings through the Administrative expenses. Administrative expenses are the expenses included in operating result, unless already included in the technical margin or the investment margin in the margin analysis of the operating result.
| 1 January to 30 | |
|---|---|
| June 2020 | |
| Staff expenses | 784 |
| Other operating expenses | 471 |
| IFRS operating expenses | 1,255 |
| Presented in non-operating items (including special items) | -128 |
| Presented in the Technical margin (claims handling expenses) | -63 |
| Presented in the Investment margin (investment expenses) | -20 |
| Administrative expenses | 1,044 |
Administrative expenses are calculated as the total of IFRS Staff expenses and IFRS Other operating expenses, adjusted for expenses already recognised in the technical margin and the investment margin and for expenses that are not included in operating result (non-operating expenses and special items). From the total administrative expenses of EUR 1,044 million, EUR 647 million relates to the segments Netherlands Life, Insurance Europe Life, Japan Life and Asset Management. The remainder of EUR 397 million is included in the operating result non-life, banking and other.
In addition, NN Group discloses a number of other metrics (that are not defined in IFRS and/or not defined in regulatory capital legislation). As these are not derived from comparable metrics under IFRS, these cannot be reconciled to an IFRS equivalent. These include the following:
Taxation on components of other comprehensive income
| 1 January to 30 | 1 January to 30 | |
|---|---|---|
| June 2020 | June 2019 | |
| Unrealised revaluations property in own use | 1 | |
| Unrealised revaluations available-for-sale investments and other | -289 | -1,212 |
| Realised gains/losses transferred to the profit and loss account | 21 | 19 |
| Changes in cash flow hedge reserve | -1,037 | -1,006 |
| Deferred interest credited to policyholders | 218 | 479 |
| Remeasurement of the net defined benefit asset/liability | 11 | |
| Income tax | -1,087 | -1,708 |
The following table presents the estimated fair value of NN Group's financial assets and liabilities. Certain balance sheet items are not included in the table, as they do not meet the definition of a financial asset or liability. The aggregation of the fair value presented below does not represent and should not be construed as representing the underlying value of NN Group.
Fair value of financial assets and liabilities
| Estimated fair value | Balance sheet value | |||
|---|---|---|---|---|
| 31 December | 31 December | |||
| 30 June 2020 | 2019 | 30 June 2020 | 2019 | |
| Financial assets | ||||
| Cash and cash equivalents | 12,388 | 6,436 | 12,388 | 6,436 |
| Financial assets at fair value through profit or loss: | ||||
| – investments for risk of policyholders | 32,288 | 34,433 | 32,288 | 34,433 |
| – non-trading derivatives | 16,431 | 10,189 | 16,431 | 10,189 |
| – designated as at fair value through profit or loss | 1,344 | 1,184 | 1,344 | 1,184 |
| Available-for-sale investments | 118,202 | 117,644 | 118,202 | 117,644 |
| Loans | 68,124 | 66,018 | 64,580 | 61,768 |
| Total financial assets | 248,777 | 235,904 | 245,233 | 231,654 |
| Financial liabilities | ||||
| Subordinated debt | 2,655 | 2,807 | 2,396 | 2,409 |
| Debt securities issued | 1,752 | 2,079 | 1,693 | 1,992 |
| Other borrowed funds | 7,100 | 7,725 | 7,027 | 7,614 |
| Investment contracts with discretionary participation features for risk of | ||||
| policyholders | 227 | 245 | 227 | 245 |
| Investment contracts for risk of company | 1,101 | 1,063 | 1,046 | 1,025 |
| Investment contracts for risk of policyholders | 1,118 | 1,135 | 1,118 | 1,135 |
| Customer deposits and other funds on deposit | 16,103 | 15,799 | 15,598 | 15,161 |
| Financial liabilities at fair value through profit or loss: | ||||
| – non-trading derivatives | 4,480 | 3,232 | 4,480 | 3,232 |
| Total financial liabilities | 34,536 | 34,085 | 33,585 | 32,813 |
For the other financial assets and financial liabilities not included in the table above, including short-term receivables and payables, the carrying amount is a reasonable approximation of fair value.
The estimated fair value represents the price at which an orderly transaction to sell the financial asset or to transfer the financial liability would take place between market participants at the balance sheet date (exit price). The fair value of financial assets and liabilities is based on unadjusted quoted market prices, where available. Such quoted market prices are primarily obtained from exchange prices for listed instruments. Where an exchange price is not available market prices are obtained from independent market vendors, brokers or market makers. Because substantial trading markets do not exist for all financial instruments, various techniques have been developed to estimate the approximate fair value of financial assets and liabilities that are not actively traded. The fair value presented may not be indicative of the net realisable value. In addition, the calculation of the estimated fair value is based on market conditions at a specific point in time and may not be indicative of the future fair value.
Further information on the methods and assumptions that were used by NN Group to estimate the fair value of the financial instruments and the sensitivities for changes in these assumptions is disclosed in Note 33 'Fair value of financial assets and liabilities' of the 2019 NN Group Consolidated annual accounts.
Financial assets and liabilities at fair value The fair value of the financial instruments carried at fair value was determined as follows:
| 30 June 2020 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Financial assets | ||||
| Investments for risk of policyholders | 31,013 | 480 | 795 | 32,288 |
| Non-trading derivatives | 15 | 16,383 | 33 | 16,431 |
| Financial assets designated as at fair value through profit or loss | 1,208 | 136 | 1,344 | |
| Available-for-sale investments | 76,523 | 40,070 | 1,609 | 118,202 |
| Financial assets | 108,759 | 57,069 | 2,437 | 168,265 |
| Financial liabilities | ||||
| Investment contracts with discretionary participation features for risk of | ||||
| policyholders | 227 | 227 | ||
| Investment contracts (for contracts at fair value) | 1,118 | 1,118 | ||
| Non-trading derivatives | 25 | 4,410 | 45 | 4,480 |
| Financial liabilities | 1,143 | 4,637 | 45 | 5,825 |
| 31 December 2019 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Financial assets | ||||
| Investments for risk of policyholders | 33,406 | 225 | 802 | 34,433 |
| Non-trading derivatives | 18 | 10,121 | 50 | 10,189 |
| Financial assets designated as at fair value through profit or loss | 1,045 | 139 | 1,184 | |
| Available-for-sale investments | 77,468 | 38,842 | 1,334 | 117,644 |
| Financial assets | 111,937 | 49,327 | 2,186 | 163,450 |
| Financial liabilities | 1,146 | 3,407 | 59 | 4,612 |
|---|---|---|---|---|
| Non-trading derivatives | 11 | 3,162 | 59 | 3,232 |
| Investment contracts (for contracts at fair value) | 1,135 | 1,135 | ||
| policyholders | 245 | 245 | ||
| Investment contracts with discretionary participation features for risk of |
This category includes financial instruments whose fair value is determined directly by reference to published quotes in an active market that NN Group can access. A financial instrument is regarded as quoted in an active market if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or regulatory agency and those prices represent actual and regularly occurring market transactions with sufficient frequency and volume to provide reliable pricing information on an ongoing basis.
This category includes financial instruments whose fair value is determined using a valuation technique (e.g. a model), where inputs in the model are taken from an active market or are observable. If certain inputs in the model are unobservable the instrument is still classified in this category, provided that the impact of those unobservable inputs elements on the overall valuation is insignificant. Included in this category are items whose value is derived from quoted prices of similar instruments, but for which the prices are modified based on other market observable external data and items whose value is derived from quoted prices but for which there was insufficient evidence of an active market.
This category includes financial instruments whose fair value is determined using a valuation technique (e.g. a model) for which more than an insignificant part of the inputs in terms of the overall valuation are not market observable. This category also includes financial assets and liabilities whose fair value is determined by reference to price quotes but for which the market is considered inactive. An instrument is classified in its entirety as Level 3 if a significant portion of the instrument's fair value is driven by unobservable inputs. Unobservable in this context means that there is little or no current market data available from which the price at which an orderly transaction would likely occur can be derived.
| Investments | Available-for | |||
|---|---|---|---|---|
| for risk of | Non-trading | sale | ||
| 30 June 2020 | policyholders | derivatives | investments | Total |
| Level 3 Financial assets – opening balance | 802 | 50 | 1,334 | 2,186 |
| Amounts recognised in the profit and loss account | -1 | -17 | -43 | -61 |
| Revaluations recognised in other comprehensive income (equity) | -14 | -14 | ||
| Purchase | 382 | 382 | ||
| Sale | -6 | -11 | -17 | |
| Maturity/settlement | -1 | -1 | ||
| Other transfers and reclassifications | -19 | -19 | ||
| Exchange rate differences | -19 | -19 | ||
| Level 3 Financial assets – closing balance | 795 | 33 | 1,609 | 2,437 |
| 31 December 2019 | Investments for risk of policyholders |
Non-trading derivatives |
Available-for sale investments |
Total |
|---|---|---|---|---|
| Level 3 Financial assets – opening balance | 788 | 85 | 1,087 | 1,960 |
| Amounts recognised in the profit and loss account | 21 | -35 | -55 | -69 |
| Revaluations recognised in other comprehensive income (equity) | -2 | -2 | ||
| Purchase | 334 | 334 | ||
| Sale | -7 | -9 | -16 | |
| Maturity/settlement | -15 | -15 | ||
| Exchange rate differences | -6 | -6 | ||
| Level 3 Financial assets – closing balance | 802 | 50 | 1,334 | 2,186 |
| Non-trading | |
|---|---|
| 30 June 2020 | derivatives |
| Level 3 Financial liabilities – opening balance | 59 |
| Amounts recognised in the profit and loss account | -14 |
| Level 3 Financial liabilities – closing balance | 45 |
| 31 December 2019 | Non-trading derivatives |
|---|---|
| Level 3 Financial liabilities – opening balance | 99 |
| Amounts recognised in the profit and loss account | -29 |
| Sale | -11 |
| Level 3 Financial liabilities – closing balance | 59 |
Level 3 – Amounts recognised in the profit and loss account during the year (2020)
| Held at balance | Derecognised during the |
||
|---|---|---|---|
| 30 June 2020 | sheet date | period | Total |
| Financial assets | |||
| Investments for risk of policyholders | -1 | -1 | |
| Non-trading derivatives | -17 | -17 | |
| Available-for-sale investments | -43 | -43 | |
| Financial assets | -61 | - | -61 |
| Financial liabilities | |||
| Non-trading derivatives | -14 | -14 | |
| Financial liabilities | -14 | - | -14 |
Level 3 – Amounts recognised in the profit and loss account during the year (2019)
| Derecognised | |||
|---|---|---|---|
| Held at balance | during the | ||
| 31 December 2019 | sheet date | period | Total |
| Financial assets | |||
| Investments for risk of policyholders | 21 | 21 | |
| Non-trading derivatives | -35 | -35 | |
| Available-for-sale investments | -55 | -55 | |
| Financial assets | -69 | - | -69 |
| Financial liabilities | |||
| Non-trading derivatives | -29 | -29 | |
| Financial liabilities | -29 | - | -29 |
In April 2020, NN Group announced the completion of its acquisition of VIVAT Schadeverzekeringen N.V. ('VIVAT Non-life'). Included below is an overview of the transaction, a description of VIVAT Non-life, the rationale for the transaction, the accounting at the acquisition date and certain additional disclosures on the acquisition.
On 7 June 2019, NN Group announced that it acquired 100% of the voting equity interest of VIVAT Non-life for a consideration of EUR 416 million. NN Group announced that it acquired VIVAT Non-life from Athora, following the acquisition of the VIVAT Group (VIVAT) by Athora. In addition, NN Group announced that it acquired the intercompany Tier 2 loans granted by VIVAT to VIVAT Non-life for a consideration of EUR 150 million plus accrued interest. The acquisition of the intercompany Tier 2 loans is considered part of the acquisition of VIVAT Non-life for IFRS accounting purposes. The approvals for the acquisition were received in the first quarter of 2020. The transaction closed on 1 April 2020. As a result, VIVAT Non-life is included in the consolidation in the reporting for the first half of 2020 as of 1 April 2020.
VIVAT Non-life is a Dutch insurance company that offers a variety of non-life insurance products. VIVAT Non-life provides mainly property & casualty and disability insurance. VIVAT Non-life operates in the Netherlands. VIVAT Non-life was a 100% subsidiary of VIVAT N.V. VIVAT N.V, was previously owned by Anbang Group Holdings Co Ltd until it was sold to Athora immediately before NN Group purchased VIVAT Non-life from Athora.
The acquisition of VIVAT Non-life by NN Group is in line with NN Group's strategic goal of long-term value creation for its stakeholders increasing operating capital generation and driving growth in attractive markets The completion of the acquisition of VIVAT Non-life adds additional scale and capabilities to NN Group's non-life platform, enabling further improvement of customer propositions and increasing NN Group's ability to invest in digital capabilities and innovation.
The acquisition of VIVAT Non-life will help achieve the strategic goals, extracting the synergy benefits from the transaction and further reducing expenses. This acquisition will enable NN Group to continue to optimise the Non-life business by building data capabilities and leveraging on its additional scale.
The acquisition date of VIVAT Non-life by NN Group for acquisition accounting under IFRS is 1 April 2020. On this date, NN Group acquired 100% of the ordinary shares in VIVAT Non-life and thus obtained control. Therefore, VIVAT Non-life is included in the NN Group consolidation from 1 April 2020.
NN Group has performed the initial accounting for the acquisition using the values below. However NN Group will recognise any adjustments to these values within a twelve month period from the acquisition date as amendments to the initial accounting as is required by IFRS 3.
The initial accounting values of certain assets and liabilities acquired as at 1 April 2020 as disclosed below differ from the values of the assets and liabilities in the balance sheet of VIVAT Non-life immediately before the acquisition by NN Group. This difference is mainly a result of the following most significant amendments as a result of the purchase price allocation as required under IFRS:
Acquisition
Acquisition date fair values of the assets and liabilities acquired (2020)
| Acquisition | |
|---|---|
| date | |
| Cash paid to acquire shares in VIVAT Non-life | 416 |
| Cash paid to acquire the intercompany Tier 2 loans (including accrued interest) | 152 |
| Cash in company acquired | -29 |
| Cash flow on acquisition | 539 |
| date | |
|---|---|
| Assets | |
| Cash and cash equivalents | 29 |
| Financial assets at fair value through profit or loss: | |
| – non-trading derivatives | 62 |
| Available-for-sale investments | 1,517 |
| Loans | 43 |
| Reinsurance contracts | 70 |
| Associates and joint ventures | 21 |
| Intangible assets | 12 |
| VOBA | 119 |
| Other assets | 128 |
| Total assets | 2,001 |
| Liabilities | |
| Subordinated debt | 171 |
| Insurance and investment contracts | 1,266 |
| Deferred tax liabilities | 16 |
| Other liabilities | 142 |
| Total liabilities | 1,595 |
| Net assets acquired - VIVAT Non-life | 406 |
| Fair value of purchase consideration | |
| - To acquire shares in VIVAT Non-life | 416 |
| - To acquire the intercompany Tier 2 loans (including accrued interest) | 152 |
| Total fair value of purchase consideration | 568 |
| Fair value of net assets acquired | |
| - Net assets acquired VIVAT Non-life | 406 |
| - Acquired intercompany Tier 2 loans | 166 |
| Total fair value of net assets acquired | 572 |
| Difference | -4 |
The difference represents negative goodwill, which is recognised in the line Other income in the profit and loss account.
| Acquisition | |
|---|---|
| date | |
| Acquisition-related costs recognised as expense | 6 |
| Total income recognised in profit and loss since date of acquisition | 196 |
| Net profit recognised in profit and loss since date of acquisition | 17 |
| Total income that would have been recognised in profit and loss if acquired from the start of the year1 | 403 |
| Net profit that would have been recognised in profit and loss if acquired from the start of the year2 | 21 |
1 The sum of Total income since the date of acquisition plus the first quarter 2020 Total income for VIVAT Non-life stand-alone.
2 The sum of Net profit since the date of acquisition plus the first quarter 2020 Net profit for VIVAT Non-life stand-alone.
Aegon's Life Insurance business in the Czech Republic and Aegon's Life Insurance and Pension businesses in Slovakia
In the first half of 2019, NN Group acquired all issued and outstanding ordinary shares of Aegon's Life Insurance business in the Czech Republic and Aegon's Life Insurance and Pension businesses in Slovakia for a total consideration of EUR 155 million. NN Group acquired multiple legal entities. For further information on this acquisition, reference is made to NN Group's Consolidated annual accounts 2019.
Reference is made to Note 42 'Legal proceedings' of the 2019 NN Group Consolidated annual accounts for a description of legal proceedings with respect to unit-linked products in the Netherlands.
On 31 March 2020, the Court of Appeal in The Hague ruled in an interim ruling in the collective action initiated by Woekerpolis.nl against NN that it wishes to refer preliminary questions to the Dutch Supreme Court to obtain clarity on various principal points of law related to unit-linked products. The collective action before the Court of Appeal in The Hague will only resume once the Dutch Supreme Court has formulated its answers to the preliminary questions.
In an interim ruling issued on 22 April 2020 the District Court in Rotterdam dismissed Wakkerpolis' claim to recalculate the value of unit-linked products without initial costs. With respect to unit-linked products issued after 1994, the District Court concluded that NN complied with information requirements prescribed by law and regulations applicable at the time and further concluded that in principle all costs (including initial costs) were agreed upon by parties (wilsovereenstemming). With respect to unit-linked products issued before 1994, NN is requested to provide the District Court with information to demonstrate that also for these unit-linked products it acted in accordance with the applicable information requirements at the time. For unit-linked products issued before 1 August 1999, the District Court concluded that policyholders were not sufficiently informed by NN on the effect of costs on the surrender value or paid up value of a policy, leading to an absence in the agreement between parties (leemte). In principle, the District Court will apply the principle of reasonableness and fairness in order to determine what the implied agreement is between parties. NN is requested to inform the District Court on whether the allocation system for initial costs used by NN would negatively affect the value of policies in case they are surrendered early or converted into paid up policies.
On 29 July 2020, the District Court in Rotterdam rejected all claims of Consumentenbond and ruled that NN has provided sufficient information on the effect of costs and premiums. The ruling of the District Court in Rotterdam is subject to appeal.
The rulings mentioned above do not change earlier statements and conclusions disclosed by NN Group in relation to unit-linked products. Although the financial consequences could be substantial for the Dutch insurance business of NN Group and, as a result, may have a material adverse effect on NN Group's business, reputation, revenues, results of operations, solvency, financial condition and prospects, it is not possible to reliably estimate or quantify NN Group's exposures at this time.
On 6 April 2020 NN Group announced that it would act in accordance with the recommendations of EIOPA and the Dutch Central Bank (DNB) published on 2 April 2020, which urged insurers to temporarily suspend their dividend distributions and share buyback programmes as a consequence of the COVID-19 pandemic.
Although NN Group is well capitalised and has a strong liquidity position, it decided to postpone the payment of dividends on its ordinary shares in line with the EIOPA and DNB recommendations. The proposal to pay a 2019 final dividend that was included in the 2019 Annual Accounts was not included in the agenda of the annual general meeting of 28 May 2020. In addition, the EUR 250 million share buyback programme, which commenced on 2 March 2020, was suspended. Up to and including 3 April 2020, shares for a total amount of EUR 183 million had been repurchased under this programme.
The proposed 2019 final dividend was already deducted from Solvency II Own Funds as at 31 December 2019 and reflected in the 2019 Solvency ratio as disclosed in the 2019 Annual Report. Following the decision not to propose a 2019 final dividend, there was no deduction in the final 2019 Solvency ratio that was filed with the regulator. As a result, the final Solvency ratio at 31 December 2019 was 224% (compared with 218% as disclosed in the 2019 Annual Report). There was no impact on shareholders' equity under IFRS.
The suspension of the share buyback programme did not impact the Solvency ratio at 31 December 2019. The shares that were bought under the programme until 3 April 2020 are deducted from shareholders' equity and own funds in the first half of 2020.
NN Group will re-start the open market share buyback programme which commenced on 2 March 2020 and which was suspended in April 2020. The remaining amount to be repurchased of EUR 67 million of the original EUR 250 million programme will be completed before 2 March 2021. NN Group intends to cancel the shares acquired under the programme. The remaining amount of the share buyback will be deducted in full from Solvency II Own Funds in the second half of 2020. It will be reflected in shareholders' equity under IFRS upon execution of the buyback transactions.
Solvency II
| 31 December | ||
|---|---|---|
| 30 June 2020 | 2019 | |
| Basic Own Funds | 19,510 | 19,491 |
| Non-available Own Funds | 1,123 | 1,252 |
| Eligible Own Funds to cover Solvency Capital Requirements (a) | 18,388 | 18,240 |
| – of which Tier 1 unrestricted | 12,235 | 11,836 |
| – of which Tier 1 restricted | 1,938 | 1,922 |
| – of which Tier 2 | 2,470 | 2,474 |
| – of which Tier 3 | 500 | 703 |
| – of which non-Solvency II regulated entities | 1,244 | 1,305 |
| Solvency Capital Requirements (b) | 8,338 | 8,154 |
| – of which Solvency Capital Requirements calculated on the basis of consolidated data | 7,852 | 7,612 |
| – of which the capital requirements for investment firms, pension funds and credit institutions | 188 | 249 |
| – of which the capital requirements for undertakings included under the D&A method | 298 | 294 |
| NN Group Solvency II ratio (a/b)1 | 221% | 224% |
1 The Solvency ratio is not final until filed with the regulators. The Solvency ratio of NN Group is based on the Partial Internal Model. The Solvency ratio at 31 December 2019 of 224% changed from the ratio disclosed in the 2019 Annual Report of 218% as a result of the decision to suspend the 2019 final dividend and the share buyback programme. Reference is made to Note 19 'Other events'.
On 11 July 2020, the Dutch Central Bank (DNB) published new regulations in which the required approach to calculating the Solvency II ratio was revised. As from 31 December 2020, NN Group will be required to include NN Bank in the calculation of its Solvency II ratio. The pro forma NN Group Solvency II ratio including NN Bank is 211% as at 30 June 2020.
The Hague, 5 August 2020
D.A. (David) Cole, chair H.M. (Hélène) Vletter-van Dort, vice-chair H.J.G. (Heijo) Hauser R.W. (Robert) Jenkins J.W. (Hans) Schoen C.C.F.T. (Clara) Streit
D.E. (David) Knibbe, CEO, chair D. (Delfin) Rueda, CFO, vice-chair
We have reviewed the accompanying condensed consolidated interim accounts as at 30 June 2020 of NN Group N.V. (the Company), The Hague, as included on pages 22 to 52 of this report. These condensed consolidated interim accounts comprise the condensed consolidated balance sheet as at 30 June 2020, the condensed consolidated profit and loss account, the condensed consolidated statement of comprehensive income, the condensed consolidated statement of changes in equity, and the condensed consolidated statement of cash flows for the six-month period ended 30 June 2020, and the notes. Management of the Company is responsible for the preparation and presentation of these condensed consolidated interim accounts in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union. Our responsibility is to express a conclusion on these condensed consolidated interim accounts based on our review.
We conducted our review in accordance with Dutch law including standard 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity'. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures.
A review is substantially less in scope than an audit conducted in accordance with Dutch Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the accompanying condensed consolidated interim accounts as at 30 June 2020 are not prepared, in all material respects, in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union.
Amstelveen, 5 August 2020
KPMG Accountants N.V.
P.A.M. de Wit RA
NN Group N.V. Schenkkade 65 2595 AS The Hague The Netherlands P.O. Box 90504, 2509 LM The Hague The Netherlands www.nn-group.com
Commercial register of Amsterdam, no. 52387534
Elements of this Condensed consolidated interim financial information contain or may contain information about NN Group N.V. within the meaning of Article 7(1) to (4) of EU Regulation No 596/ 2014 (Market Abuse Regulation).
NN Group's Consolidated Annual Accounts are prepared in accordance with International Financial Reporting Standards as adopted by the European Union ('IFRS-EU') and with Part 9 of Book 2 of the Dutch Civil Code.
In preparing the financial information in this document, the same accounting principles are applied as in the NN Group N.V. 2019 Annual Accounts, unless indicated otherwise in Note 1 'Accounting policies' in the Condensed consolidated interim accounts for the period ended 30 June 2020.
All figures in this document are unaudited. Small differences are possible in the tables due to rounding. Certain of the statements contained herein are not historical facts, including, without limitation, certain statements made of future expectations and other forward-looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Actual results, performance or events may differ materially from those in such statements due to, without limitation: (1) changes in general economic conditions, in particular economic conditions in NN Group's core markets, (2) the effects of the Covid-19 pandemic and related response measures, including lockdowns and travel restrictions, on economic conditions in countries in which NN Group operates, on NN Group's business and operations and on NN Group's employees, customers and counterparties (3) changes in performance of financial markets, including developing markets, (4) consequences of a potential (partial) break-up of the euro or European Union countries leaving the European Union, (5) changes in the availability of, and costs associated with, sources of liquidity as well as conditions in the credit markets generally, (6) the frequency and severity of insured loss events, (7) changes affecting mortality and morbidity levels and trends, (8) changes affecting persistency levels, (9) changes affecting interest rate levels, (10) changes affecting currency exchange rates, (11) changes in investor, customer and policyholder behaviour, (12) changes in general competitive factors, (13) changes in laws and regulations and the interpretation and application thereof, (14) changes in the policies and actions of governments and/or regulatory authorities, (15) conclusions with regard to accounting assumptions and methodologies, (16) changes in ownership that could affect the future availability to NN Group of net operating loss, net capital and built-in loss carry forwards, (17) changes in credit and financial strength ratings, (18) NN Group's ability to achieve projected operational synergies, (19) catastrophes and terrorist-related events, (20) adverse developments in legal and other proceedings and (21) the other risks and uncertainties contained in recent public disclosures made by NN Group.
Any forward-looking statements made by or on behalf of NN Group speak only as of the date they are made, and, NN Group assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or for any other reason.
This document does not constitute an offer to sell, or a solicitation of an offer to buy, any securities.
© 2020 NN Group N.V.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.